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 ABSTRACT 
 
 The circadian system in mammals is arranged as a hierarchical network of 
oscillators, with the master pacemaker of circadian rhythms located in the 
suprachiasmatic nuclei (SCN) of the hypothalamus and peripheral oscillators in most 
other organ and tissue systems of the body. The molecular machinery responsible for 
generating circadian rhythms is composed of interlocked transcriptional-translational 
feedback loops with the gene Brain Muscle Arnt-like 1 (Bmal1) functioning as a core 
positive regulator. Using the mouse, Mus musculus as a model system, we studied the 
post-transcriptional mechanisms regulating Bmal1 expression in the SCN pacemaker and 
in peripheral oscillators.  
Target prediction algorithms were used to identify microRNAs (miRNAs) 
predicted to target Bmal1. We profiled the temporal expression of miR-142-3p in the 
mouse SCN in vivo and in an immortalized SCN cell line and observed robust circadian 
rhythms in its expression in the SCN. Following luciferase-reporter and site-directed 
mutagenesis analyses, we identified miR-142-3p as a bona-fide post-transcriptional 
repressor of Bmal1. The temporal expression of potential Bmal1-targeting miRNAs was 
also examined in the circulation in mouse serum. In mice housed in a light-dark cycle, 
diurnal oscillations were observed in serum levels of miR-152 and miR-494, but not 
miR-142-3p expression. Luciferase reporter studies indicated that miR-494, both 
independently and synergistically with miR-142-3p, repressed the Bmal1 3′ UTR. 
Overexpression of these miRNAs disrupted ensemble circadian rhythms of 
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 PER2::LUCIFERASE activity in cultured fibroblasts. Overexpression of the miRNAs 
also increased their extracellular levels and their intracellular accumulation in recipient 
cultures exposed to conditioned medium. Furthermore, inhibition of exocytosis and 
endocytosis affected ensemble circadian rhythms in cultured fibroblasts.  
The results thus implicate miR-142-3p and miR-494 in the regulation of Bmal1 
expression in the SCN and peripheral oscillators and suggest that miRNAs may function 
as both, intracellular and extracellular (cis- and trans- acting) signals, modulating the 
core clock mechanism in the SCN and in fine-tuning the synchronization of circadian 
rhythmicity between cell-autonomous oscillators in the periphery. 
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 CHAPTER I 
INTRODUCTION  
 
Life on earth has evolved on a planet that rotates on its axis and revolves around 
a star. This ‘eternal’ motion, influenced by interactions with the moon orbiting around it, 
generates distinct, repeating environmental changes that most organisms have adapted 
to. One of the ways these adaptations manifest are as endogenous rhythms that cycle in 
synchrony with the cyclic changes occurring in the environment. One cycle can last for 
~12h (circatidal), one day (circadian), twenty eight days (circalunar) or one year 
(circannual).  
 
Circadian Rhythms- Evolutionary Context 
Circadian rhythms, derived from latin roots ‘circa’ meaning ‘about’ and ‘diem’ 
meaning ‘day’ are cyclic changes in an organisms behavior, physiology, metabolism and 
gene expression that occur with a period of about one day. Circadian rhythms are 
pervasive in nature and are observed in photosynthetic cyanobacteria and in most 
eukaryotes including fungi, plants and mammals. The widespread occurrence of 
circadian clocks in diverse species is suggestive of evolutionary pressure to maintain 
them. The presence of an endogenous clock is thought to provide an evolutionary 
advantage in allowing an organism to anticipate the predictable changes in 
environmental conditions including temperature, food-availability, and predation risk. 
However, systematic rigorous tests of the evolutionary importance of clocks are 
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 cumbersome. Additionally, a laboratory, where animals cannot interact with the myriad 
of other species and factors they are normally exposed to in their natural environment is 
not an ideal setting for testing evolutionary importance of clocks. There has, hence, been 
limited experimentation of evolutionary questions.  
Increased fitness: The suprachaiasmatic nuclei (SCN), as detailed in the 
succeeding sections, are the seat of the master pacemaker of circadian rhythms in 
mammals. Because SCN-lesioned animals are known to loose most circadian rhythms, 
DeCoursey and colleagues (1997) monitored mortality rates of intact or SCN-lesioned 
antelope ground squirrel in a semi-natural field setting. The experimenters observed a 
significantly higher mortality rate in SCN-lesioned animals compared to the intact 
control counterparts. The second, even more convincing study compared mortality rates 
of free living, wild caught chipmunks after SCN lesions or Sham operations (DeCoursey 
et al., 2000). Between 14-60 days after surgeries, the mortality rate of the SCN-lesioned 
animals was significantly higher than the sham operated or the non-operated animals. 
 The resonance hypothesis: Using genetic manipulations, it has been possible to 
carry out more robust studies in plant and cyanobacterial systems by testing the 
‘circadian resonance’ hypothesis. These experiments test the prediction that since life on 
earth has evolved to take advantage of 24h cycles, genetic mutations generating 
organisms with endogenous free-running periods (FRP’s) different from that of the wild-
type’s will be at a competitive disadvantage in a 24h cycle. As a corollary, wild-type 
individuals would be predicted to be outcompeted if they are housed with mutants in an 
environment where T-cycles (‘T’ = zeitgeber; ‘cycle’ = period) are more compatible to 
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 the FRP’s of the mutants rather than the wild-types. In one such study on Arabidopsis, 
Dodd and colleagues (2005) exposed wild-type and clock mutant plants to 20h, 24h or 
28h light-dark cycles. They measured chlorophyll, carbon-fixing ability and vegetative 
growth under competition and monoculture conditions. In all cases, accurate matching of 
the plants endogenous cycle with the external light-dark cycle was most advantageous 
for growth and survival whereas circadian dissonance (i.e., endogenous rhythms not 
aligned with environmental cycles) was disruptive for growth and survival.   
Some of the best evidence for the adaptive value of endogenous clocks obtained 
so far has come from similar competition experiments using the cyanobacteria, 
Synechococcus elongatus. Ouyang and colleagues (1998) utilized three strains of the 
cyanobacteria, which had different endogenous free-running periods. The wild type 
strain had a FRP of ~25h, the short period mutant had a period of ~23h and the long 
period mutant had a period of ~30h. Competition experiments were performed by 
exposing pairwise mixtures containing equal proportions of two strains to light-dark T-
cycles of 22h, 24h or 30h. In all instances, the strains with endogenous FRP closest to 
the environmental cycle out-competed the other strain. These two lines of research 
provide compelling evidence in support of the importance of preservation of functional 
circadian rhythms in natural/pseudo-natural environments.  
 
Formal Properties of Circadian Rhythms 
 The study of circadian clocks involves analysis and understanding of cyclic, 
mostly sinusoidal, phenomenon and many terms otherwise associated with physics are 
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 used while describing circadian rhythms. Zeitgeber (‘zeit’ meaning ‘time’ and ‘geber’ 
meaning ‘giver’) is an exogenous rhythmic environmental stimulus that can act as an 
indicator of external time. Phase of a rhythm is any defined instantaneous point on a 
sinusoidal wave. Peak is the phase of highest expression and a trough is the phase of 
lowest expression. Period of a rhythm is the time taken for a defined reference phase to 
recur during the subsequent cycle (e.g. time between two subsequent peaks, or two 
subsequent troughs). Amplitude of a rhythm is a measure of the mean difference 
between the peak and trough phase of one cycle.  
Because multiple examples of biological processes repeating with rhythmic 
sinusoidal patterns can be otherwise found in nature, three basic characteristics need to 
be fulfilled before a cyclic biological phenomenon can be considered as a circadian 
rhythm (Pittendrigh, 1960; Aschoff et al., 1971; Bell-Pedersen et al., 2005). These are as 
follows: 1) the process cycles with a period close to 24h and the cycles are maintained 
under constant conditions (Fig. 1A). The persistence of circadian rhythms under constant 
environmental conditions such that processes ‘free-run’ with a period determined by an 
internal clock demonstrates the ‘endogenous’ biological origin of the rhythm. The free-
running periods of circadian rhythms differ slightly from the 24h period of 
environmental light-dark cycles. 2) The phase and period of the rhythm can be entrained 
by environmental cycles (Fig. 1B). Considering that clocks are an adaptation to ensure 
that different biological processes occur at the optimal time during an environmental 
cycle, it is necessary for these clocks to adjust to potential changes in the environment. 
This phenomenon of adjusting to align overt rhythmicity is called ‘entrainment’ to an
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Figure 1. Free-running and entrainment characteristics of circadian rhythms. 
Representative locomotor behavior (wheel running) activity of WT mice maintained in 
(A) constant darkness (DD), or (B) 12h: 12h LD cycle, with shaded regions representing 
the dark phase. The actograms are double-plotted. Reprinted from Experimental 
Neurology, 232 /1, Takashi Kudo, Dawn H. Loh, Danny Truong, Yingfei Wu, 
Christopher S. Colwell, Circadian dysfunction in a mouse model of Parkinson's disease, 
66-75, Copyright (2011), with permission from Elsevier. 
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 environmental cycle. 3) The last universal feature of circadian rhythms is that the period 
of the rhythm remains stable even at various different (but ambient) temperatures. This 
property is called temperature compensation. Most biochemical reactions are 
temperature-dependent and typically exhibit a Q10 value of 2-3; that is, the rate of a 
reaction increases 2-3 folds for every 10-degree rise in temperature. However, since 
organisms are exposed to varying temperatures during the course of a day and over the 
course of a year, it is vital that the circadian clocks are buffered against variations in 
temperature to allow them to accurately predict and entrain to environmental time. The 
period of circadian rhythms are hence ‘temperature compensated’ and exhibit Q10 values 
of ~1.1, which are significantly less than what would be expected in the absence of any 
compensation. 
 
Functional Organization of Circadian Timekeeping Systems 
Circadian clocks have been described in many diverse species from distinct taxa. 
All clocks however share a common overall organization; they all contain three parts: 
input pathway(s), central oscillator(s) and output pathway(s). The input pathway(s) 
transmit environmental information (e.g. light intensity, temperature, osmotic balance, 
etc.) to the central oscillator. The central oscillator is the timekeeping mechanism, 
composed of molecular and biochemical interactions between clock-components that 
give rise to self-sustained rhythmic oscillations. The central oscillator can be entrained to 
environmental cycles via the input pathways, but can also free-run in the absence of 
external input. The output pathways are responsible for translating information from the 
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 central oscillator to generate overt circadian rhythms in gene expression, physiology, 
metabolism and behavior in an organism.   
 
Circadian Rhythms in Mammals 
Hierarchical organization: The mammalian circadian timekeeping system is 
thought to have a hierarchical organization with the suprachiasmatic nuclei (SCN) of the 
anterior hypothalamus functioning as the master pacemaker responsible for temporal 
synchronization of various cell-autonomous oscillators present in the central nervous 
system and in peripheral tissues. The importance of the SCN was uncovered via initial 
lesion studies trying to identify location(s) in the brain responsible for generation or 
maintenance of circadian rhythms. In rats, bilateral electrolytic lesions of the SCN 
resulted in global loss of circadian rhythms in physiology and behavior, implicating the 
SCN as the location for generation of circadian rhythms and their entrainment to 
environmental light-dark cycles (Moore and Eichler, 1972; Stephan and Zucker, 1972). 
The lesion experiments were later followed up by transplantation studies in which fetal 
SCN tissue was transplanted into SCN-ablated host animals. Transplantation was found 
to rescue behavioral circadian rhythmicity in previously arrhythmic animals (Lehman et 
al., 1987; Silver et al., 1990). Additionally, using Tau, a short period mutant strain, 
Ralph et al. (1990) showed that the free-running period of the restored rhythms was 
determined by the transplanted SCN tissue. Transplanting fetal SCN from wild-type or a 
long period mutant (mCry-/-) into host mice harboring mutations that rendered them 
otherwise arrhythmic, Sujino et al. (2003) further showed that a functional circadian 
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 clock in the SCN is sufficient to drive some, if not all, circadian rhythms in animals and 
that the free-running period of those rhythms is determined by the endogenous properties 
of the SCN. These studies corroborated the role of the SCN as a central pacemaker 
mediating the maintenance of circadian rhythms in mammals.  
Structure and function of the SCN: The suprachiasmatic nuclei are a set of 
paired structures containing approximately 10,000 neurons each, and are located on 
either side of the third ventricle in the anterior hypothalamus, superior to the optic 
chiasm. The SCN receive light input from melanopsin-expressing intrinsically 
photoreceptive retinal ganglion cells (iPRGCs) via the retinohypothalamic tract (RHT) 
(Hattar et al., 2002; Do and Yau, 2010). RHT fibers form mono-synaptic connections 
with retinorecipient cells in the ventral ‘core’ region of the SCN and this photic 
communication occurs through the release of neurotransmitters, glutamate and pituitary 
adenylate cyclase activating peptide (PACAP) (Abrahamson and Moore, 2001; Morin 
and Allen, 2006). The neurons comprising the core region of the SCN are enriched for 
the expression of neuropeptides vasoactive intestinal polypeptide (VIP) and gastrin 
releasing peptide (GRP). This ventrolateral core densely projects into the surrounding, 
dorsomedial ‘shell’ region of the SCN, which contain neurons enriched for production of 
the neuropeptide arginine vasopressin (AVP) (Leak et al., 1999; Abrahamson and 
Moore, 2001). In addition to neurons, the SCN also contains glial cells, which also 
contain functional circadian clocks that contribute to SCN pacemaking function (Prosser 
et al., 1994; Michel and Colwell, 2001; Prolo et al., 2005). 
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 Many cellular and molecular processes in the SCN are marked by intrinsic 
rhythmicity even in the absence of any external input from the retina. Self-sustained 
oscillations in gene expression, metabolism, neurotransmitter secretion and neuronal 
firing rate have been observed in the SCN in vivo and in vitro (Schwartz et al., 1980; 
Groos and Hendriks, 1982; Earnest and Sladek, 1986; Gillette and Reppert, 1987; Bos 
and Mirmiran, 1990; Newman et al., 1992; Panda et al., 2002; Reppert and Weaver, 
2002). Using a transgenic reporter line, Yamazaki and colleagues (2000) showed that 
circadian rhythms in expression of luciferase, under control of a clock gene (Per1) 
promoter, persist for up to 32 days in the rat SCN in vitro. Our studies similarly indicate 
that immortalized SCN cells from transgenic mice generate cell-autonomous circadian 
rhythms in gene expression for up to 7 days in culture (Farnell et al., 2011). 
Furthermore, endogenous circadian rhythmicity is not just an ensemble property, but is a 
characteristic of individual cells of the SCN as well. Neurons of the SCN continue to 
express independently phased rhythms in firing rate even when maintained in dissociated 
cultures in vitro (Welsh et al., 1995).  
Various studies that will be discussed in detail in the succeeding sections have 
now established that cell-autonomous rhythmicity is not only a property of cells of the 
SCN, but is actually pervasive in most peripheral tissues as well. What makes the SCN 
unique, however, is the ability to drive or synchronize rhythms in other cells. The SCN 
pacemaker function appears to be mediated by secretion of diffusible factors. Silver and 
colleagues (1996) modified SCN transplantation experiments such that the donor SCN 
was encapsulated in a permeable membrane to determine whether transplant-host 
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 synaptic connections were necessary to restore circadian rhythmicity in SCN-ablated 
host animals. The primary observations of this study were that despite the physical 
barrier between graft and host cells, these SCN transplants still restored the circadian 
rhythm of locomotor activity, suggesting that some diffusible signal(s) may mediate 
SCN pacemaker function. Parallel studies by Allen and colleagues (2001) using an 
immortalized rat SCN cell line (SCN2.2) that retained SCN pacemaking properties 
(Earnest et al., 1999) provide further evidence for the role of diffusible signals in SCN 
pacemaker function. In a co-culture environment allowing communication of diffusible 
factors but not physical contact between different cell types, the capacity of NIH/3T3 
fibroblasts to generate rhythms in gene expression and metabolism was dependent on 
their co-culture with SCN2.2 (and presumably on some SCN-specific signals responsible 
for conveying this rhythmicity). Although the identities of these diffusible signals are 
still being investigated, prokineticin 2, TGF-α and cardiotrophin-like cytokine (CLC) 
have emerged as potential candidates mediating SCN-controlled rhythms in locomotor 
activity (Kramer et al., 2001; Cheng et al., 2002; Kraves et al., 2006).  
Although the presence of diffusible signals has been unequivocally 
demonstrated, other studies also highlight the requirement of neural connections for 
effective SCN pacemaking function in generating synchronized physiological and 
endocrine rhythms (Meyer-Bernstein et al., 1999; Guo et al., 2005; Guo et al., 2006). 
Using anterograde tracer and retrograde dyes, extensive projections of the SCN have 
been identified. These projections are predominantly to other parts of the hypothalamus 
and to some regions of the thalamus. Specifically, these include, the medial preoptic 
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 area, paraventricular nucleus of the thalamus (PVA), paraventricular nucleus of the 
hypothalamus (PVN), dorsomedial nucleus of the hypothalamus (DMH), medial and 
lateral subparacentricular zone (sPVZ) among others (Watts et al., 1987; Watts and 
Swanson, 1987; Kalsbeek et al., 1993; Leak and Moore, 2001). These brain regions in 
turn are involved in regulation of physiological and behavioral outputs like metabolism, 
sleep and feeding (reviewed by: Saper et al., 2005; Kalsbeek et al., 2007). Thus, SCN 
neural projections impinge on different brain centers, potentially modulating the 
regulation of certain rhythmic behaviors like feeding and sleep.  
Molecular clock machinery- the transcriptional-translational feedback loop 
model: The molecular machinery responsible for the generation of circadian rhythms has 
been extensively studied over the past two decades. The result is a transcriptional-
translational feedback loop (TTFL) model, in which genes comprising the positive 
elements drive transcription of negative elements that feed-back to inhibit their own 
transcription. An ancillary feedback loop is thought to stabilize the core loop (Fig. 2). 
The products of the core clock genes also undergo post-translational modifications that 
set the speed of the clock such that the period of one oscillatory cycle is approximately 
24h (reviewed by, Lowrey and Takahashi, 2011). 
The positive factors that drive the molecular machinery are Clock and Bmal1. 
Both genes encode basic helix-loop-helix transcription factors that heterodimerize during 
the day, when CLOCK-BMAL1 activity is at its peak, and drive transcription via E-box 
(-CACGTG-) enhancer elements in the promoters of their target genes (King et al., 1997; 
Gekakis et al., 1998; Bunger et al., 2000). The negative elements, Per1, Per2, Cry1 and 
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 Cry2, which contain E-boxes or E’-boxes in their promoters are transcribed, translated in 
the cytosol where they form complexes that are then translocated back into the nucleus 
(Van Der Horst et al., 1999; Vitaterna et al., 1999; Bae et al., 2001; Zheng et al., 2001). 
Once in the nucleus, the PER-CRY complex inhibits CLOCK-BMAL1 transcriptional 
activity, in turn shutting off their own transcription. This inhibition is thought to occur 
via direct CRY-mediated interactions with, and repression of, the CLOCK-BMAL1 
heterodimer (Kume et al., 1999; Sato et al., 2006). Additionally, the PER-CRY complex 
is thought to recruit histone modifying enzymes, like HDAC1, to aid in repression of 
transcription at clock-specific promoters (Duong et al., 2011).  
Genes comprising one of the ancillary loops containing orphan nuclear receptors, 
Rora and Rev-erbα, are also transcriptionally activated by CLOCK-BMAL1 
heterodimers. Additionally, the Bmal1 promoter contains RevErbA/ROR-binding 
elements (ROREs), which are the sites of action of the two Ror’s and Rev-erb’s. Rora is 
an activator of Bmal1 transcription, while Rev-erbα is a repressor (Fig. 2) (Preitner et al., 
2002; Sato et al., 2004; Akashi and Takumi, 2005).  
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Figure 2. Simplified model of the mammalian circadian transcriptional translational 
feed-back loop oscillator mechanism. Reprinted from Human Molecular Genetics, 15 
(Suppl 2): R271-R277, Caroline H. Ko and Joseph H. Takahashi, (2006), with 
permission from Oxford University Press. 
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 Post-translational modifications of clock proteins: Successful reconstitution of a 
cyanobacterial, Synechococcus elongatus, clock in vitro without any transcriptional 
input, provided the first major indication of the potential importance and sufficiency of 
transcription-independent mechanisms in clock cycling (Nakajima et al., 2005; Tomita et 
al., 2005). Although these observations are not entirely applicable in mammals, post-
transcriptional events important in fine-tuning the molecular clockwork have been 
discovered (reviewed by, Gallego and Vishrup, 2007). Phosphorylation of the PER 
proteins by casein kinase ε (Csnk1e) was the first such modification identified. The 
phosphorylation of PER2 affects its proteasomal degradation and PER1 nuclear entry 
(Vielhaber et al., 2000; Eide et al., 2005). Indeed, the Tau mutation first identified in 
hamsters and resulting in dramatically short (~20h) free-running period of locomotor 
activity was cloned to the Csnk1e locus (Lowrey et al., 2000). Other kinases involved in 
phosphorylation of clock proteins include casein kinase 2 (Csnk2a and Csnk2b) which 
targets components of both the positive limb (BMAL1) and the negative limb (PER2) for 
phosphorylation (Tamaru et al., 2009; Tsuchiya et al., 2009), glycogen synthase-kinase 
β, which has also been shown to phosphorylate: 1) PER2 and promote its nuclear 
localization, 2) CRY2 so as to  promote its degradation, and 3) BMAL1and prime it for 
ubiquitination (Harada et al., 2005; Iitaka et al., 2005; Sahar et al., 2010). The mitogen 
activated protein kinase (MAPK) and protein kinase c (PKC) are also implicated in 
phosphorylation of BMAL1 and inhibition of CLOCK-BMAL1 heterodimer activity 
(Sanada et al., 2002; Robles et al., 2010). Rhythmic phosphorylation is also balanced in 
part by protein phosphates, PP5 and PP1, which target CK1ε and PER2 respectively for 
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 de-phosphorylation (Gallego et al., 2006; Partch et al., 2006). Focusing on Bmal1, the 
primary clock gene of interest for this dissertation, other post-transcriptional 
modifications including sumoylation, acetylation, deacetylation and ubiquitination have 
also been reported. Three SUMO paralogs (SUMO 1, 2 and 3), all target BMAL1 
recruiting it for ubiquitination and proteasomal degradation (Cardone et al., 2005; Lee et 
al., 2008). CLOCK protein, the partner of BMAL1, has acetyl transferase activity and 
acetylates the 537-lysine residue on BMAL1 (Doi et al., 2006). This is reversed by an 
NAD+ dependent deacetylase, SIRT1, which binds to CLOCK-BMAL1 and influences 
circadian gene expression (Hirayama et al., 2007; Nakahata et al., 2008; Bass and 
Takahashi, 2011). 
Post-transcriptional regulation of the circadian clock: Although transcription 
regulation has been the primary focus of most studies examining the underpinnings of 
the molecular clock machinery, post-transcriptional mechanisms have garnered 
increasing interest as an additional regulatory layer (reviewed by, Staiger and Koster, 
2011; Cibois et al., 2010). Initial studies in Drosophila highlighted that rhythmic Per 
mRNA degradation was regulated at the post-transcriptional level (So and Rosbash, 
1997). This was recently also observed for mammalian Per2 (Woo et al., 2009). AU-rich 
regions (ARE’s) in the 3’ untranslated region (UTR) of Per2 mRNA are targeted by the 
RNA-binding protein, polypyrimidine tract-binding protein 1 (PTBP1), promoting 
degradation of Per2 transcripts. A similar mechanism involving the heterogenous 
nuclear riboprotein D (hnRNPD) was described in post-transcriptional regulation of 
Cry1 mRNA transcript as well (Woo et al., 2010). Some RNA-binding proteins, rather 
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 than causing mRNA degradation, function to stimulate translation instead. One such 
protein, LARK (RBM4), binds to cis- elements in the Per1 3’ UTR and promotes its 
translation (Kojima et al., 2007). MicroRNAs (miRNAs) are another important class of 
post-transcriptional regulators that are known to function as master switches regulating a 
variety of biological processes, including circadian rhythms. Mechanisms of miRNA 
biogenesis and action, particularly in modulating circadian rhythms biology, will be 
discussed in detail in the succeeding sections.  
Peripheral clocks- rhythms and synchronization: Cell-autonomous oscillations 
are not a property only of the SCN but that of all other cells of the body as well. 
Circadian rhythms in the expression of core clock genes and of other clock-controlled 
genes have been described in various peripheral tissues (Kita et al, 2002; Panda et al., 
2002; Storch et al., 2002; Yamamoto et al., 2004). Interestingly, using transgenic mice 
expressing a PER2::LUCIFERASE reporter, Yoo et al. (2004) also showed that 
peripheral tissues continue to express self-sustained rhythms for up to 20-cycles in 
isolation (out of the body). Importantly, the same report showed that SCN ablation did 
not abolish rhythms in individual tissues, but it did however cause some loss of 
synchrony in rhythms among peripheral oscillators, indicating that rather than ‘drive’ 
rhythms, the SCN may primarily functions to synchronize clocks in peripheral tissues. 
Additionally, serum-shock treatment was shown to induce cycling of core clock genes 
and the clock-controlled gene DBP, in Rat-1 fibroblasts. These rhythms in mRNA 
expression cycled for 2-3 days and provided preliminary evidence that circadian 
rhythmicity is a cell-autonomous property of cells even outside the SCN (Balsalobre et 
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 al., 1998). More convincing evidence was provided in studies using Bmal1-luc and 
PER2::LUC reporters to monitor bioluminescence rhythms in individual fibroblasts. 
Clock gene rhythms in individual cells were observed to persist, even after the damping 
of ensemble oscillations due to loss of intercellular synchronization (Welsh et al., 2004).  
Thus cell-autonomous oscillations are the underlying characteristic of clocks, in 
the SCN and throughout the body as well. However, mechanisms of interaction between 
individual clocks to produce ensemble synchronization are yet unclear. The identities of 
potential signaling factors responsible for this synchronization, either within local 
environments in the SCN or in peripheral tissues, or systemically between different 
tissues or organ systems provide exciting avenues for investigation. Based on details 
provided in the preceding sections, these signals are likely to be diffusible. Given their 
presence in membrane-bound vesicles in the circulation, and evidence for 
communication between cells, miRNAs, which act as master switches of gene 
expression, provide potential candidates capable of communicating temporal information 
between cells and functioning in synchronization of circadian oscillators within local 
environments.  
 
Non-coding RNAs- Historical Perspective 
 The central dogma of biology for decades had been that DNA is transcribed into 
RNA, which is then translated into proteins. However, it is now clear that the functions 
of RNA extend well beyond just the transmission of DNA-encoded heritable information 
to corresponding peptides and proteins. Indications of potential non-coding functions of 
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 RNA’s were initially provided by genomic analyses revealing that the number of 
protein-coding genes had previously been vastly overestimated. Only about 20,000-
25,000 protein coding genes, representing approximately 3-5% of the total euchromatin, 
were identified in the human genome (International Human Genome Sequencing 
Consortium, 2004). Although the remaining non-protein coding 95-97% of euchromatin 
was initially considered “junk”, high-resolution studies have now revealed that RNAs 
encoded from these regions are associated with vital regulatory functions that control 
development, physiology and pathologies (Pennisi, 2012). Indeed, non-coding RNAs 
have garnered increased attention for their biological importance, and based on ratios of 
non-coding to genomic DNA, some posit that regulatory RNAs may play vital roles in 
complexity of organisms (Mattick, 2007). The recent ENCODE project described 8800 
small RNA molecules that do not code for any proteins. MicroRNAs (miRNAs) are a 
sub-type of such non-coding RNAs and provide the primary focus of this dissertation. 
 
Discovery and Biogenesis of MicroRNAs 
Discovery: The first studies describing short temporal RNAs (stRNAs), now 
termed miRNAs, were simultaneously published from the laboratories of Victor Ambros 
and Gary Ruvkun (Lee et al., 1993; Wightman et al., 1993). In these studies, a small 
RNA lin-4 was reported to mediate post-transcriptional regulation via specific sequences 
in the 3’ untranslated region (UTR) of a developmental gene lin-14 in C. elegans. 
Furthermore, the lin-14 3’ UTR was necessary and sufficient for this lin-4 mediated 
regulation. Seven years later, another report implicated let-7, a small 21nt RNA in the 
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 regulation of developmental timing in C. elegans by interactions with the 3’ UTRs of 
target genes including lin-14 (Reinhart et al., 2000). Importantly, while lin-4 is found 
only in worms, let-7 is highly conserved across vertebrates and in some invertebrates as 
well (Pasquinelli et al., 2000). Since then, interest in miRNAs has exploded and miRNA 
databases currently estimate presence of more than 2000 human, 1200 mice, 400 fly and 
350 worm mature miRNAs, many of which have already been empirically validated 
(Griffiths-Jones, 2004).  
Biogenesis- transcription: miRNAs are found at two locations in the genome- in 
the introns of genes and in intergenic regions, either independently or as a cluster of 
multiple miRNAs, presumably transcribed together. Recent estimates indicate that 
approximately 40-50% of human miRNAs are intronic, with intergenic miRNAs 
distributed as clusters or independent miRNAs in an approximately 1:1 ratio (Lagos-
Quintana et al., 2003; Rodrigues et al., 2004; Saini et al., 2007). Generally, miRNAs are 
thought to be transcribed by RNA polymerase II to generate a primary-miRNA (pri-
miR) transcript with a 5’ cap as well as 3’ poly(A) tail (Lee et al., 2002; Lee et al., 
2004). However, there is some evidence for RNA polymerase III-mediated transcription 
of miRNA biogenesis as well (Faller and Guo, 2008). Additionally, many miRNAs are 
expressed in a tissue specific manner and transcriptional regulators have also been 
shown to induce or inhibit expression of specific miRNAs (reviewed by, Zhang and 
Zeng, 2010).  
Biogenesis- canonical miRNA maturation pathway: Following transcription, 
miRNAs undergo processing before reaching functional maturity (Fig. 3). While other 
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 mechanisms have also been identified, the canonical miRNA biogenesis pathway 
involves sequential processing by two RNase III enzymes. In the first step, a primary 
miRNA (pri-miRNA) transcript, containing characteristic hairpin loop(s), is acted upon 
the nuclear RNase III endonuclease, DROSHA, along with its partner DGCR8. The 
DROSHA/DGCR8 microprocessor complex cleaves off the hairpin loop leaving a 5’ 
phosphate and 2-3nt long 3’ overhang (Lee et al., 2003; Gregory et al., 2004). This 
cleavage product is ~70nt long and is designated as a premature miRNA (pre-miRNA). 
Pre-miRNA(s) are transported out of the nucleus by exportin-5 in a Ran-GTP mediated 
mechanism (Yi et al., 2003; Lund et al., 2004). Once in the cytoplasm, the pre-miRNA is 
further cleaved by the cytoplasmic RNase III endonuclease, DICER to give two size-
matched single stranded ~19-23nt transcripts (Bernstein et al., 2001; Hutvagner et al., 
2001). Thus, each pre-miRNA can potentially code for two mature miRNAs; in some 
cases both are associated with biological functions. For example, premature miR-142 
codes for two functional mature miRNAs miR-142-5p and miR-142-3p. However, in 
some cases only one strand is functional and the other is degraded. For example, mature 
miR-152 is generated from the 3’ tail of the premature miR-152 stem-loop structure, 
while the corresponding miRNA generated from the 5’ tail is preferentially degraded.  
The canonical maturation pathway involving DROSHA and DICER is primarily 
attributed to biogenesis of clustered or individual intergenic miRNAs. However, ~30-
40% of miRNAs are also present in intronic regions and are frequently transcribed as 
part of the premature mRNA transcript (Rodriguez et al., 2004; Baskerville and Bartel, 
2005). Although it was initially assumed that miRNA processing begins after cleavage 
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 of the intron by the splicing machinery, the canonical DROSHA-dependent pathway can 
also cause cleavage of the hairpin pre-miRNA before splicing events (Kim and Kim, 
2007). The splicesome-independent canonical miRNA maturation pathway can thus 
provide for co-expression of both the miRNA and mRNA transcripts. 
Biogenesis- non-canonical miRNA maturation pathways: Intronic miRNAs are 
also processed in a DROSHA-independent manner, and hence termed the non-canonical 
pathway. First identified in Drosophila, some short hairpin introns were mapped 
precisely to splice-acceptor and -donor sites. Splicing of these introns generates a 
functional pre-miRNA independent of DROSHA activity (Fig. 3). The pre-miRNA is 
exported to the cytoplasm, and cleaved by DICER, yielding mature miRNAs (Okamura 
et al., 2007; Ruby et al., 2007). Given their intronic origin, these DROSHA-independent, 
DICER-dependent miRNAs were later termed ‘mirtrons’ and have now been identified 
in mammalian and avian species as well (Berezikov et al., 2007; Glazov et al., 2008). 
Yet other non-canonical DROSHA-independent miRNAs arising out of t-RNAs or endo-
shRNAs have also been described (reviewed by, Miyoshi et al., 2010; Yang and Lai, 
2011). A recently discovered non-canonical pathway involves DROSHA-dependent, but 
DICER-independent processing and maturation of miR-451. The primary transcript, pri-
miR-451 is cleaved by DROSHA to generate a pre-miR-451 that contains a ~18nt duplex 
stem which is too short to be recognized by DICER for cleavage. This transcript instead 
is acted upon by AGO2 to generate a longer than average (~30nt) miR-451, which is 
later trimmed down to a 23nt form (Cifuentes et al., 2010; Yang et al., 2010). It should 
be noted that miR-451 is conserved only among vertebrates.   
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Figure 3. Simplified model of canonical and non-canonical pathways for biogenesis of 
mature miRNAs in animals. Reprinted from Molecular Cell, 43 /6, Jr-Shiuan Yang and 
Eric C. Lai, Alternative miRNA Biogenesis Pathways and the Interpretation of Core 
miRNA Pathway Mutants, 892-903, Copyright (2011), with permission from Elsevier. 
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 Target Recognition and Biological Action of MicroRNAs 
RISC loading: Mature miRNAs associate with the RNA-induced silencing 
complex (RISC) and affect their biological activity. In the cytoplasm, DICER, stabilized 
by its partner TRBP, associates with Argonaute-2 (AGO2) and forms the RISC loading 
complex (RLC). In the cytosol, pre-miRNA hairpins associate with the RLC and 
undergo processing by this complex to generate mature miRNAs (Chendrimada et al., 
2005; Gregory et al., 2005; MacRae et al., 2008). After cleavage of the pre-miRNA 
transcript, DICER and TRBP are thought to dissociate from the RCL allowing for the 
duplex to unwind and incorporate the mature strand into the RISC. Mechanistic details 
of whether the unwinding involves a dedicated helicase are unclear. However, AGO2 
has been shown to catalyze the process in an ATP-independent fashion (Maniataki et al., 
2005). Additionally, AGO2 has also been shown to create single-stranded nicks without 
DICER involvement, and hence may also catalyze miRNA processing. Thus AGO2 
could potentially have a dual-role, as a helicase and an RNase (Diederichs et al., 2007).  
Target recognition: Mature miRNAs interact with complementary sequences 
primarily in the 3’ UTRs of their target genes. This interaction is generally characterized 
by imperfect pairing due to some mismatches in complementarity between the miRNA 
and its target in the 3’ UTR. However, an important factor for miRNA activity is perfect 
base pairing between nucleotides 2-8 of the miRNA and the target 3’ UTR. This region 
of the miRNA, primarily responsible for target recognition and specificity, is called the 
‘seed’ region and in vitro reporter assays indicate that 7-8mer sites complementary to 
seed region of candidate miRNAs are sufficient for repression of the target 3’ UTRs 
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 (Doench and Sharp, 2004; Brennecke et al., 2005). Some evidence also indicates that 
seed region complementarity is not always sufficient for repression and that miRNA 
nucleotides 15-19 may also have significant functional implications as 3’ supplementary 
or 3’ compensatory regions (Grimson et al., 2007). 
Biological action: Fundamental observations on miRNA function in repressing 
translation were derived from initial experiments on C. elegans. The lin-4 miRNA was 
found to inhibit protein synthesis after initiation of translation (Olsen and Ambros, 
1999). Additional mechanisms have now been discovered and miRNA-mediated 
regulation has also been observed at the translation initiation step (reviewed by, 
Filipowicz et al., 2008). Human let-7 miRNA inhibits translational initiation in a 5’ cap 
dependent manner. The inhibition was relieved when the 5’ cap was replaced by an 
internal ribosome entry site (IRES), indicating that let-7 binding to the 3’ UTR 
potentially disrupts eukaryotic initiation factor (eIF) recognition of the 5’ cap region 
(Humphreys et al., 2005; Pillai et al., 2005). Recent studies comparing protein 
production simultaneously with mRNA expression inferred that in mammalian systems, 
the predominant mode of miRNAs biological activity involves mRNA destabilization 
(Baek et al., 2008; Guo et al., 2010). Nevertheless the primary outcome of miRNA-
mRNA interactions results in repression of protein levels. There is however some 
contradictory evidence that implicates miRNAs in up-regulation of their target mRNAs 
(Vasudevan et al., 2007). In this study, repression by miRNAs was observed during the 
proliferative phase, but the same miRNAs switched from repressing to activating their 
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 targets upon arrest of the cell cycle. It is yet unknown whether this is a global 
phenomenon or is specific to the miRNA(s) studied during this specific analysis. 
 
Contribution of MicroRNAs to Circadian Timekeeping  
Critical contributions of miRNAs have been demonstrated in a multitude of 
biological processes including development, cell cycle, metabolism, immune function, to 
name a few (Ambros, 2004; Bartel, 2004). Recently, miRNA mediated regulation has 
been described in the circadian timekeeping mechanism as well. In a pioneering study, 
Cheng et al. (2007) reported that two miRNAs, miR-219 and miR-132, were both 
rhythmically expressed in the mouse SCN. Knockdown experiments revealed that miR-
219 and miR-132 modulate the free-running period of locomotor activity and amplitude 
of phase-resetting after a light-pulse, respectively. The miRNAs are involved in 
regulation of cellular excitability and also indirectly modulate the core clock genes Per1 
and Per2. Following this initial report, rhythmic miRNA expression was also described 
in Drosophila and in Arabidopsis (Yang et al., 2008; Sire et al., 2009). In the chicken 
retinal photoreceptors a rhythmic miRNA, miR-26a, was shown to regulate the 1c 
subunit of L-type voltage gated calcium channels providing for potential modulation of 
core clock outputs (Shi et al., 2009). Another miRNA, miR-122, was shown to modulate 
amplitude of circadian expression of numerous genes in the mouse liver, including those 
involved in rhythmic regulation of metabolism (Gatfield et al., 2009). A bona-fide role 
for miRNAs in regulating clock outputs was recently revealed in studies demonstrating 
that miR-279 modulates Drosophila rest-activity rhythms via targeting the JAK/STAT 
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 pathway ligand unpaired (Upd). Knockout of the miRNA however did not affect the core 
clock gene Per, indicating that the miRNA-mediated regulation was downstream of the 
clock (Luo and Sehgal, 2012). The first evidence of miRNA involvement in core clock 
mechanisms was derived from the observation that in Drosophila, the miRNA, bantam, 
targets clock mRNA via multiple canonical sites in the clock 3’ UTR. Other interesting 
clock-related targets pulled down during the AGO1 immunoprecipitation experiment 
were virille (vri) and clockworkorange (cwo) (Kadener et al., 2009). A study reporting 
miRNA mediated regulation of a core clock component in mammals involved the miR-
192/194 cluster of miRNAs that target the mammalian Per genes (Nagel et al., 2009).  
 
Extracellular MicroRNAs  
Discovery and significance: While miRNAs perform their primary biological 
functions intracellularly, an exciting line of investigation has recently focused on the 
study of miRNAs that are expressed extracellularly. One of the first reports in this area 
involved retrospective analysis for the presence and expression of diffuse B-cell 
lymphoma (dBCL) associated miRNAs in serum samples from diseased patients. In this 
study, miR-155, miR-21 and miR-210 were upregulated in patient sera when compared 
to healthy controls (Lawrie et al., 2008). A far more extensive study demonstrated that 
numerous miRNAs were expressed in human plasma (Mitchell et al., 2008). The most 
salient findings of the study were: 1) endogenous human miRNAs from donor plasma 
were stable at room temperature for up to 24h (the length of time examined), 2) 
endogenous miRNAs from plasma were resistant to multiple cycles of freeze-thaw (eight 
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 cycles were tested), 3) exogenous ‘naked’ (not protected) miRNAs spiked-in to plasma 
were rapidly degraded (presumably by endogenous RNases in plasma) and 4) addition of 
denaturing solution containing RNase inhibitor prevented degradation of spiked-in 
exogenous miRNAs in plasma. Circulating extracellular miRNAs were also shown to be 
resistant to exogenous RNaseA mediated digestion, suggesting that this miRNA pool 
may be enclosed in some protective membrane (Chen et al., 2008; Gilad et al., 2008; 
Hunter et al., 2008). Expression of extracellular miRNAs has now been observed in 
many biological fluids including saliva, breast milk, amniotic fluid and urine (Weber et 
al., 2010). Because miRNAs are associated with many pathological states, profiling of 
extracellular miRNAs has generated tremendous interest for their potential use as 
diagnostic and prognostic biomarkers, primarily of cancers, but including other diseases 
as well (Kosaka et al., 2010a; Wang et al., 2010a; Gao et al., 2011; Mizuno et al., 2011; 
Zham et al., 2011).  
Membrane- or protein- bound extracellular miRNAs: Given that the analyses of 
extracellular miRNAs are only in their infancy, it is not surprising that there is currently 
a debate regarding whether circulating miRNAs are vesicle encapsulated or protein-
bound. Two recent reports claimed that a majority of extracellular miRNAs did not 
sediment at ultracentrifugation speeds used to precipitate microvesicle and exosomal 
content, and instead co-fractionated with protein complexes rather than with vesicles 
(Fig. 4). Further analyses revealed a role for AGO2 in binding to and stabilization of 
extracellular miRNAs (Arroyo et al., 2011; Turchinovich et al., 2011). Another study, 
also using ultracentrifugation, detected the presence of some RNA-binding proteins in 
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 the extracellular environment and concluded that the protein nucleophosmin 1 (NPM1) 
may be involved in miRNA- binding and stabilization extracellularly (Wang et al., 
2010b).  
Nevertheless, there is also clear evidence for presence of miRNAs in vesicles like 
microvesicles and exosomes which have a typical lipid bilayer structure enclosing a 
central lumen (Fig. 4). Different types of vesicles can be distinguished primarily by their 
size and intracellular origin (reviewed by, Thery et al., 2009). Microvesicles constitute 
the largest of the secreted vesicles with diameters of more than 100nm and have been 
observed to be released from various cell types, including some tumors, neutrophils and 
dendritic cells. Microvesicles are thought to form at the cell surface by outward budding 
of the plasma membrane (Chen et al., 2012). In contrast, exosomes are smaller in size 
and generally between 30-100nm in diameter. Exosomes arise out of multi-vesicular 
endosomes (MVE’s) which are formed when plasma membrane proteins transfer to an 
early endosome by inward budding. Fusion of the intraluminal components with early 
endosomes forms multivesicular bodies (MVB’s) which are sorted either for lysosomal 
degradation or for release by plasma membrane fusion. Exosomes are vesicles formed 
inside MVB’s and are released into extracellular environments upon fusion of the MVB 
with the plasma membrane of the cell (Chen et al., 2012).  
Intercellular communication: There is evidence that the miRNA constituents of 
both microvesicles and exosomes are transferred between cells. Using GFP-expressing 
embryonic stem cells, Yuan et al. (2009) recently showed that microvesicles dock with 
and transfer fluorescent signal to recipient cells. Additionally, exposure of mouse 
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 embryonic fibroblasts to miRNA containing ES-cell culture derived microvesicles 
resulted in an increase in corresponding intracellular miRNA expression in the recipient 
cells. Considering that exosomal content can be sorted before assembly into MVB’s, 
more robust evidence exists regarding the involvement of this vesicle sub-type in 
communication of extracellular miRNAs. In a pioneering study, Valadi and colleagues 
(2007) demonstrated that human and mouse mast cell derived exosomes shuttle cargo 
between cells. The salient findings of their study were: 1) exosomal RNA was devoid of 
18s and 28s rRNA species and thus preferentially enriched for small RNA’s (< 200nt 
long), 2) although exosomes expressed ~8% all of the mRNA species expressed in cells, 
there was no correlation between cellular RNA and exosomal RNA expression (i.e., 
exosomal RNA was not merely an outcome of cellular RNA distribution), suggesting 
active sorting mechanism(s) may regulate packaging of RNAs into exosomes, 3) similar 
to mRNA expression, exosomes contained miRNAs, but some miRNA species had 
higher extracellular (in exosomes) expression compared to their intracellular levels (in 
donor cells), 4) MC9 derived exosomes exhibited specificity, in delivering their cargo 
only to MC9 recipient cells but not to CD4 cells, thus implying that exosomes may 
mediate specificity of signaling as well. These findings were further extended by 
mechanistic analysis of the miRNA secretion pathway demonstrating that miRNA 
release was regulated by the enzyme neutral sphingomyelinase 2 (nSMase2), which is 
responsible for biosynthesis of the sphingolipid, ceramide (Kosaka et al., 2010b). 
Inhibition of this ceramide-dependent pathway by a pharmacological drug or by siRNA-
mediated knockdown of nSMase2 reduced miRNA secretion, while overexpression of 
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 nSMase2 had a stimulatory effect. Importantly, exosomes were also found to transfer 
their miRNA cargo from donor to recipient cells, with the transferred miRNAs 
exhibiting biological activity in the recipient cells (Kosaka et al., 2010b). Recent studies 
of antigen-presenting cells (APC) provide further indication that miRNA release is 
regulated by nSMase2 via a ceramide-dependent pathway (Fig. 4) (Mittelbrunn et al., 
2011).  
How extracellular vesicles transfer their cargo to recipient cells is largely 
unknown. Considering vesicles, especially microvesicles, contain cell surface markers 
unique to their parental cells, it is possible that receptor-ligand interactions may play a 
role in endocytosis or membrane docking. Certainly preferential uptake of microvesicles 
has been reported previously (Cocucci et al., 2009; Simons and Raposo, 2009). 
However, the mechanistic details of vesicle specificity and uptake are yet unknown.  
Other than microvesicles and exosomes, high-density lipoproteins (HDL) have 
been implicated in the trafficking of extracellular miRNAs. In a recent study, HDL-
bound miRNAs were detected in plasma and their export out of cells was regulated by 
nSMase2. Additionally, the results indicate that scavenger receptor class B type I is 
involved in mediating uptake of the HDL-bound miRNAs into recipient cells, where the 
miRNAs retained their biological activity (Vickers et al., 2011).   
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Figure 4. Simplified model of various pathways for secretion and uptake of extracellular 
miRNAs. Reprinted from Trends in Cell Biology, 22 /3, Xi Chen, Hongwei Liang, 
Junfeng Zhang, Ke Zen and Chen-Yu Zhang, Secreted microRNAs: a new form of 
intercellular communication, 125-132, Copyright (2012), with permission from Elsevier. 
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 Summary and Specific Aims  
Circadian clocks regulate rhythms in molecular, behavioral and physiological 
processes in animals. The suprachiasmatic nuclei (SCN) of the anterior hypothalamus 
function as the master pacemaker of circadian rhythms in mammals. The gears of the 
clock have now been dissected, resulting in the identification of ‘core’ and ‘regulatory’ 
elements of the clock. Current evidence indicates that rhythmic transcription is not the 
sole requirement for generation of circadian rhythms, but post-transcriptional and post-
translational processes are also critical for robust rhythmicity.  
MicroRNAs (miRNAs) are small non-coding RNAs that bind to 3’UTR’s and 
regulate translation or stability of target mRNAs. Although miRNAs have been 
implicated in regulating the timing of numerous biological events, their relative 
contribution to the hierarchical organization of the circadian timekeeping system in 
mammals is unclear. The central hypothesis of my dissertation research is that miRNAs 
are important cis- and trans-acting regulators of core clock components in the circadian 
timekeeping mechanism. To test this hypothesis, my dissertation experiments first 
examined the role of intracellular miRNAs in regulation of the core molecular clock 
gene, Bmal1, in the SCN pacemaker and in peripheral oscillators. Because recent studies 
indicate that miRNAs are not just expressed intracellularly, but are also packaged in 
vesicles, transported extracellularly and communicated locally to other cells (Valadi et 
al., 2007; Kosaka et al., 2010b), I have also conducted studies examining the role of 
extracellular miRNAs in communication of temporal information between autonomous 
circadian clocks in peripheral cell types.  
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 Specific Aim 1: Are miRNAs involved in regulation of core clock genes and 
circadian rhythmicity in the SCN? Comparisons of rhythmic transcriptome and proteome 
indicate that about ~50-89% of rhythmically-regulated proteins have corresponding 
mRNA transcripts with non-rhythmic profiles (Panda et al., 2002; Storch et al., 2002; 
Reddy et al., 2006; Deery et al., 2009). This observation suggests that post-
transcriptional and/or post-translational processes may play a significant role in 
regulating circadian rhythmicity. Because miRNAs function as post-transcriptional 
regulators modulating the timing of various biological events (Ambros, 2004; Poethig, 
2009), the objective of this aim is to test whether: 1) specific miRNAs target the 
3’UTR’s of clock genes, 2) clock-gene-targeting miRNAs are expressed rhythmically in 
the SCN, and 3) miRNAs regulate circadian rhythmicity in SCN cells. 
Specific Aim 2: Are clock-gene targeting miRNAs expressed extracellularly? 
Recent studies have indicated that miRNAs, encapsulated in vesicles, are present in the 
circulation and that their levels change in different pathological and physiological states 
(Hunter et al., 2008; Mitchell et al., 2008). Because rhythmicity is a prevalent property 
among core and regulatory elements of the circadian clockworks in most cells and 
tissues throughout the body, the objective of this aim is to test whether: 1) specific 
miRNAs with clock genes as predicted targets are expressed in serum, 2) their 
expression is marked by daily fluctuations in vivo, and 3) rhythmic miRNAs affect 3′ 
UTR activity of their target clock gene(s). Although serum could predominantly be 
associated with systemic signals, it could also be considered a local environment for 
hematopoietic and vasculature-associated cells. Thus, serum miRNAs could function 
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 locally within these cell types, or globally as systemic cues between peripheral organs. 
Additionally, it is unlikely that the SCN would be contributing to miRNAs circulating in 
serum. Serum miRNAs are more likely to be contributed by peripheral, rather than 
central nervous system oscillators and, as such, may be important indicators or 
modulators of circadian rhythms in peripheral oscillator populations. 
 Specific Aim 3: Are extracellular miRNAs involved in temporal synchronization 
of circadian rhythmicity in peripheral oscillators? Endogenous rhythmicity is a 
characteristic not only of the SCN, but also of peripheral tissues (Yamazaki et al., 2000; 
Yoo et al., 2004). It remains unknown what factors contribute to synchronization of 
rhythms within or between different peripheral tissues. Because secreted vesicles may 
mediate exchange of molecular signals like miRNAs between cells (Valadi et al., 2007; 
Yuan et al., 2009), to the objective of this aim is to test whether: 1) miRNAs modulate 
clock gene protein levels and alter rhythms in core components of the molecular 
clockworks in a peripheral oscillator model, 2) overexpression of miRNAs increases 
their extracellular abundance in culture medium, 3) exposure to miRNA containing 
conditioned medium from donor cells increases intracellular levels of the corresponding 
miRNAs in recipient cells, 4) the internalized miRNAs are functional in recipient cells, 
and 5) disruption of vesicular communication using exocytosis and endocytosis 
inhibitors affects ensemble circadian rhythms.  
This dissertation describes experiments associated with these specific aims as 
well as the results and conclusions obtained thereof.  
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 CHAPTER II 
ROLE OF miR-142-3p IN THE POST-TRANSCRIPTIONAL REGULATION OF 
THE CLOCK GENE Bmal1 IN THE MOUSE SCN 
 
Introduction 
In mammals, the suprachiasmatic nuclei (SCN) of the anterior hypothalamus 
function as the master pacemaker mediating the generation and light-dark entrainment of 
circadian rhythms (Turek, 1985; Ralph et al., 1990). In addition to coordinating 
circadian rhythmicity in other brain regions and peripheral tissues, the SCN also 
generates ensemble and cell-autonomous circadian oscillations in many of its cellular 
and molecular processes independent of external input (Schwartz et al., 1980; Groos and 
Hendriks, 1982; Shibata et al., 1982; Boos and Mirmiran, 1990; Panda et al., 2002). 
These endogenous oscillations are especially prevalent in the expression of genes 
comprising the molecular clockworks and thus vital to the circadian oscillator and 
pacemaker functions of the SCN. Brain, muscle ARNT-like protein 1 (Bmal1), circadian 
locomotor output cycles kaput (Clock), Period (Per1& Per2), the Cryptochrome (Cry1 
& Cry2) genes, and Rev-erbα are rhythmically regulated in interlocked feedback loops 
that comprise the molecular clockworks common to both SCN and peripheral cells.  
While post-translational processes including phosphorylation, ubiquitination, 
sumoylation, and acetylation have garnered the most attention for their role in the 
regulation of the molecular clockworks (Lee et al., 2001; Gallego and Vishrup, 2007), 
recent studies suggest that post-transcriptional mechanisms may also play a role in the 
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 modification of clock proteins and oscillatory regulation of components in the circadian 
feedback loops (Kojima et al., 2011; Staiger and Koster, 2011). In this regard, 
microRNAs (miRNAs) have been implicated in the post-transcriptional regulation of the 
mammalian circadian clock mechanism. Mature miRNAs are small non-coding RNAs, 
usually 19-25 nucleotides in length, that interact with miRNA-recognition elements 
(MRE) in the 3’ untranslated regions (UTR) of target genes to induce mRNA de-
stabilization and/or translational repression (Lee et al., 2003; Bernstein et al., 2001; 
Bartel, 2004; He and Hannon, 2004). Evidence for miRNA function in SCN clock 
control of circadian rhythms is derived from observations indicating that in the SCN, 
miR-219 and miR-132 exhibit circadian rhythms of expression and antagonism of these 
miRNAs respectively alters the circadian period and light-induced phase shifts of the 
mouse activity rhythm (Cheng et al., 2007). In addition, miRNAs have been linked to 
circadian clock function in peripheral tissues as antisense inhibition of miR-122 
expression induces post-transcriptional perturbations in the circadian expression of many 
genes involved in hepatic lipid and cholesterol metabolism (Gatfield et al., 2009).  
Despite the increasing evidence that miRNAs are involved in the regulation of 
mammalian circadian rhythms, little is known about the role of specific miRNAs as 
modulators of essential components of the molecular clockworks. In Drosophila, the 
miRNA, bantam, has been shown to regulate clock translation via interactions with 
multiple target sites within the clock 3’ UTR (Kadener et al., 2009). The primary 
objective of the present study was to determine whether specific miRNAs contribute to 
the post-transcriptional regulation of Bmal1. Because previous studies indicate that miR-
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 142-3p and miR-494 may act synergistically and modulate Bmal1 3’ UTR activity 
(Shende et al., 2011), we examined the role of these miRNAs in the post-transcriptional 
regulation of the molecular clock by determining whether: 1) miR-142-3p is 
rhythmically expressed in the SCN in vivo and in an immortalized SCN cell line; and 2) 
miRNA overexpression affects endogenous BMAL1 protein rhythms in SCN cells.  
 
Materials and Methods 
Animals and SCN tissue collection: Experimental subjects were 40 male 
C57BL/6J mice at 6-8 weeks of age (JAX Mice & Services, Bar Harbor, ME). Animals 
were maintained in the vivarium at Texas A&M University System Health Science 
Center under a standard 12h light: 12h dark cycle (LD 12:12; lights-on at 0600h). Five 
animals were housed per cage and access to food and water was provided ad libitum. 
Periodic animal care was performed at random times. All procedures used in this study 
were approved by the University Laboratory Animal Care Committee at Texas A&M 
University.  
To determine whether miR-142-3p expression fluctuates rhythmically in the SCN 
in vivo, mice were maintained in LD 12:12 for 3 weeks prior to experimental analysis 
and then exposed to constant darkness (DD) beginning at lights-off in the LD 12:12 
cycle (1800h). Beginning 15 hours later (0900h or circadian time [CT] 3), animals were 
sacrificed at 4h intervals (n=5) for 24h by decapitation using an infrared viewer (FJW 
Optical Systems, Palatine, IL). SCN tissue was immediately dissected as described 
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 previously (Earnest and Sladek, 1986; Liang et al., 1998). All tissue samples were frozen 
in liquid nitrogen and stored at -80°C until further processing. 
Cell culture: For in vitro analysis, immortalized SCN cell lines generated from 
mPer2Luc knockin and from Per1ldc / Per2ldc mice were used to profile the temporal 
pattern of miR-142-3p expression. These cell lines were maintained and propagated as 
described previously (Farnell et al., 2011). Briefly, cells were grown on laminin-coated 
60mm dishes (Corning, Inc.) in Minimal Essential Medium (MEM; Invitrogen, Inc.) 
containing 10% Fetal Bovine Serum (FBS), 3000μg/ml glucose, and 292μg/ml L-
glutamine. The medium was replaced every 48h and cultures were split 1:3 to 1:5 every 
3-4 days. Prior to experimentation, cells were expanded onto laminin-coated 6-well 
plates (BD Biosciences, Inc.). Approximately 24h after plating, the medium was 
changed so as to reduce the FBS concentration to 5% and on the following day cells 
were rinsed with calcium-magnesium free (CMF) buffer and then cultured in serum-free 
Neurobasal medium containing B27 supplement (1X, Invitrogen, Inc.). Cultures (n=5) 
were harvested at 4h intervals for 36h by trypsinization and cell pellets were flash frozen 
in liquid nitrogen.  All samples were stored at -80°C until subsequent analysis of 
miRNA or mRNA content. 
RNA extraction and Real-time PCR: cellular RNA was later extracted from 
individual SCN tissue samples and individual wells of mPer2Luc and Per1ldc/Per2ldc SCN 
cells using miRNeasy kit (Qiagen, Inc.) according to the manufacturer’s protocols. Total 
RNA was estimated using Nanodrop ND2000 (Thermo Scientific). Quantitative real-
time PCR analysis for miR-142-3p was conducted using Taqman microRNA assays 
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 (Applied Biosystems) as described previously (Shende et al., 2011). Briefly, miR-142-3p 
from individual samples was reverse transcribed using Taqman MicroRNA Reverse 
Transcription Kit and the cDNA equivalent of 1.5ng of total RNA was PCR amplified in 
an ABI PRISM 7500 Fast sequence detection system using the following standard 
conditions: 1) heating at 95ºC for 10 min, and 2) amplification over 40 cycles at 95ºC for 
15 sec and 60ºC for 1 min. As an endogenous control, U6 snRNA was also amplified 
from the same samples using identical parameters. Using the comparative CT method 
described in the ABI Prism 7700 Sequence Detection System User Bulletin #2 (PE-
ABI), the relative abundance of miR-142-3p was calculated by normalization first to 
corresponding U6 snRNA levels in each sample and then to a calibrator consisting of 
pooled cDNA from multiple samples over the entire time series.  
Relative quantification of Bmal1 mRNA abundance in all samples was 
performed using SYBR-Green real-time PCR technology (ABI) as described previously 
(Allen et al., 2004; Farnell et al., 2008). To generate single-strand cDNAs, total RNA 
(1µg) from individual samples was reverse transcribed using random hexamers and 
Superscript III reverse transcriptase Kit (Invitrogen, Inc.).  Real-time PCR analysis of 
was performed on duplicate aliquots using the cDNA equivalent of 1ng of total RNA for 
each sample. The PCR cycling conditions were: 1) serial heating at 50ºC for 2min and 
95ºC for 10min, 2) amplification over 40 cycles at 95ºC for 15 sec and 60ºC for 1 min, 
and 3) dissociation at 95ºC for 15 sec, 60ºC for 1min, 95ºC for 15 sec and 60ºC for 15sec. 
To provide an endogenous control, cyclophilin A (Ppia) was amplified with the cDNA 
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 equivalent of 1ng total RNA from the same samples. The comparative CT method was 
similarly applied to determine the relative expression of mBmal1 mRNA.  
The following primers were used for the real-time PCR analysis:  
mBmal1 forward: 5'- CCAAGAAAGTATGGACACAGACAAA -3'; 
mBmal1 reverse: 5'- GCATTCTTGATCCTTCCTTGGT -3'; 
mCyclophilin forward: 5’- TGTGCCAGGGTGGTGACTT -3’; 
mCyclophilin reverse: 5’- TCAAATTTCTCTCCGTAGATGGACTT -3’.  
Western Blotting: The effects of miR-142-3p overexpression on endogenous 
levels of mBMAL1 protein were examined in cultures of mPer2Luc SCN cells that were 
derived from a single passage. Cells were expanded on laminin-coated 60-mm dishes 
(Corning, Inc.) maintained at 37°C and 5% CO2 in MEM (Invitrogen, Inc.) 
supplemented with 3000 ug/mL D-glucose, 292 ug/mL L-glutamine and 10% Fetal 
Bovine Serum (Hyclone). Prior to experimentation, mPer2Luc SCN cells were seeded 
onto laminin-coated 6-well plates, and 24h later cultures were transfected with pEZX-
MR04 miRNA expression vector for miR-142-3p (final conc. = 4.0ug per well) using 
Lipofectamine 2000 (Invitrogen, Inc.) according to the manufacturer’s guidelines. 
Control cultures were similarly transfected with a pEZX-MR04 vector encoding a 
scrambled, non-targeting control sequence. Following transfection for 5h, cells were 
rinsed and cultured in growth medium supplemented with 5% FBS. On the following 
day, cells were rinsed with calcium-magnesium free (CMF) buffer and then maintained 
in serum-free Neurobasal medium containing B27 supplement (1X, Invitrogen, Inc.). 
Beginning 12h later, control and miR-142-3p-transfected cultures (n=5) were harvested 
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 at 4h intervals for 24h by trypsinization and cell pellets were flash frozen in liquid 
nitrogen. All samples were stored at -80°C until subsequent processing. The pellets were 
sonicated in mammalian protein extraction reagent (MPER; Pierce, Inc.) supplemented 
with protease inhibitor cocktail (PMSF), and sample protein content in cell homogenates 
was measured using the bicinchoninic acid method (BCA Protein Assay Kit; Thermo 
Scientific Pierce). Each sample was loaded at ~20μg protein lysate per lane onto a 10% 
Tris-Glycine gel and electrophoresis was performed using an X-blot Mini-cell II 
apparatus (Invitrogen, Inc.). Following separation at 125V for 2h, proteins were 
transferred onto 0.45μm nitrocellulose membranes (Invitrogen) and blocked at room 
temperature for 1 hour with 5% skimmed milk in Tris-buffered saline (TBS) 
supplemented with 0.1% Tween-20 (TBS-T). With interceding rinses in TBS-T, 
membranes were probed overnight at 4oC with rabbit anti-BMAL1 (1:250; Abcam, Inc.) 
or a mouse monoclonal antibody against β-ACTIN (1:2000; Sigma Inc.) followed by a 
1-hour incubation with horse-radish preoxidase (HRP)-conjugated donkey anti-rabbit 
IgG (1:1000; Jackson Laboratories) or goat anti-mouse IgG (1:2000; Jackson 
Laboratories). Immunoreactive signal for BMAL1 was generated using enhanced 
chemiluminescence (ECL) reagent (Thermo Scientific Pierce) and luminescence for 
size-appropriate bands were detected using a FluorChem Gel imaging system (Alpha 
Innotech Corp.). To control for differences in protein content between samples, signal 
intensity measurements for BMAL1 were normalized to the values for β-ACTIN in each 
sample. Densitometric analyses for immunoreactive bands were performed using NIH 
ImageJ software. 
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 Statistical analyses: Time-dependent fluctuations in mmu-miR-142-3p and 
Bmal1 mRNA expression were identified by cosine curve-fitting analysis using 
GraphPad Prism software. With α=0.05, waveform fittings with p-values < 0.01 were 
considered statistically significant and therefore characterized by circadian variation. For 
waveforms characterized as rhythmic, peak values and those observed during the 
preceding or succeeding minimum were analyzed post hoc for statistical differences 
using independent t-tests. BMAL1 protein expression was first analysed by one-way 
analysis of variance (ANOVA). Paired comparisons between peak values and those 
observed during the preceding or succeeding minimum were analyzed post hoc for 
statistical differences using the Newman-Keuls sequential range test. The α-value was 
set at 0.05 for these post hoc analyses. Independent t-tests were performed on 
normalized luciferase bioluminescence data to determine the significance of miRNA-
mediated repression of luciferase-reported Bmal1 3’ UTR activity. The α-value was set 
at 0.05 for all independent t-tests.  
 
Results 
The circadian clock regulates rhythmic expression of mature miR-142-3p: 
Given our previous findings implicating miR-142-3p and miR-494 as potent repressors 
of the Bmal1 3’ UTR, we investigated potential clock-related mechanisms regulating 
expression of these miRNAs. Upstream regions of the miRNA loci were examined for 
evidence of E-box or CRE-box elements, which are known to drive rhythmic 
transcription under control of the circadian clock and light respectively. The presence of  
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Figure 5. Prediction of canonical E-box element upstream of the mouse miR-142 locus. 
Diagrammatic representation of a well conserved ‘-CACGTG-’ sequence located from 
bases 87569031-87569036, upstream of the miR-142 locus on the plus strand of mouse 
chromosome 11.  
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 a canonical, CACGTG, E-box element was identified ~1.5Kb upstream of the miR-142 
locus and analysis of syntenic regions indicated that this element is highly conserved 
among mammalian lineages (Fig. 5). Since miR-494 is located in a cluster of 21 
miRNAs spanning ~10-kb of the mouse chromosome 12, regulatory elements 
contributing specifically to miR-494 transcription could not be identified.  
The presence of an E-box indicated that miR-142 locus may be under 
transcriptional control by CLOCK-BMAL1. We next examined the temporal profiles of 
mature miR-142-3p expression in the SCN in vivo. Rhythmic fluctuations were observed 
in the relative expression of miR-142-3p (normalized to U6 snRNA; p<0.01) in the 
mouse SCN in DD (Fig. 6A). SCN expression of miR-142-3p peaked at CT 3 during the 
early subjective day and was significantly, and about 2-fold higher than trough levels 
observed ~12h later around early subjective night at CT 15 (p<0.001). Analysis of 
Bmal1 expression in the same samples corroborated previous reports examining 
circadian variation in SCN content of Bmal1 mRNA (normalized to Cyclophilin; 
p<0.0001) with expression peaking during the late subjective night (CT 23) and reaching 
a nadir during the mid-subjective day around CT 7 (Fig. 6A) (Honma et al., 1998; 
Maywood et al., 2003). The peak in Bmal1 expression was significantly greater than the 
corresponding trough levels (p<0.001). Additionally, Bmal1 mRNA levels in the mouse 
SCN peaked ~4h in advance of the crest in miR-142-3p expression, suggestive of Bmal1 
involvement in the activation of miR-142-3p transcription.  
To determine whether miR-142-3p expression is also rhythmically regulated in 
vitro, studies were conducted in mPer2Luc SCN cells because this immortalized line has 
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 been shown to retain the endogenous rhythm-generating properties of the SCN (Farnell 
et al., 2011). Similar to the temporal profile for miR-142-3p expression in vivo, levels of 
mature miR-142-3p were rhythmic (normalized to U6 snRNA, p<0.0001) in cultured 
mPer2Luc SCN cells (Fig. 6B). The amplitude of rhythmic miR-142-3p expression was 
robust, with 3- to 4-fold differences between peak and trough values. The maxima 
observed at 12h and 36h were significantly greater than the nadir attained at 20h 
(p<0.05). Bmal1 mRNA expression was also rhythmic (normalized to Cyclophilin; 
p<0.0001) in the same mPer2Luc SCN cultures. The circadian peaks in Bmal1 mRNA 
expression observed at 0h and 24h were ~2-fold greater than the preceding and 
succeeding troughs observed at 8h and 36h. The observed Bmal1 mRNA rhythm was 
antiphasic to the circadian profile in miR-142-3p expression from the same samples (Fig. 
6B).  
To verify that the observed rhythms in miR-142-3p expression were under 
control of the circadian clock, the temporal profile of miR-142-3p levels were analyzed 
in an SCN cell line derived from mice with targeted disruption of Per1 and Per2 genes 
(Per1ldc ⁄Per2ldc SCN) because: 1) these mutant mice exhibit an arrhythmic behavioral 
phenotype (Bae et al., 2001), and 2) our previous findings indicate that circadian 
pacemaking properties are similarly abolished in this cell line (Farnell et al., 2011). In 
Per1ldc ⁄Per2ldc SCN cells, both Bmal1 and miR-142-3p expression remained largely at 
constant levels and showed no significant evidence of circadian rhythmicity (p>0.05) 
(Fig. 6C), indicating that the observed oscillations in miR-142-3p expression were 
indeed regulated by the circadian clock.  
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Figure 6. Temporal patterns of miR-142-3p and Bmal1 in mouse SCN tissue and 
immortalized SCN cell lines. Symbols denote real-time PCR determinations of miR-142-
3p (red traces) normalized to U6 snRNA or Bmal1 (blue traces) normalized to 
Cyclophilin (mean ± SEM) collected at 4-hour intervals (n = 4-5). The plotted values 
correspond to the miR-142-3p and Bmal1 ratios in SCN tissue from C57BL/6J mice 
during exposure to constant darkness (DD) (A), mPer2Luc SCN cell line (B), and in SCN 
Per1ldc/Per2ldc cell line (C) and are represented as a percentage of the maximal value 
obtained for each gene. Asterisks indicate time points during which peak values for gene 
expression were significantly greater (p<0.05) than those observed during preceding or 
succeeding minima. 
46 
 
  
Figure 7. Temporal patterns of BMAL1 protein in immortalized mouse SCN cell line. 
Symbols denote optical densitometry determinations of BMAL1 protein expression 
(mean ± SEM) collected at 4-hour intervals (n = 4-5) from pEZX-MR04 miR-142 
expression vector (red trace) or pEZX-MR04 control miRNA expression vector (black 
trace) transfected mPer2Luc SCN cells. The plotted values correspond to ratios of 
BMAL1 protein normalized to β-ACTIN expression in each sample. Asterisks indicate 
time points during which peak BMAL1 expression was significantly greater (p<0.05) 
than those observed during succeeding minima or during the corresponding time point in 
miR-142-3p transfected samples.  
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 miR-142-3p disrupts BMAL1 protein rhythms in vitro: To investigate 
functional implications of miR-142-3p in the regulation of circadian rhythms, we next 
determined whether overexpression of miR-142-3p affects ensemble circadian rhythms 
of BMAL1 protein expression in cultured mPer2Luc SCN cells. Endogenous BMAL1 
protein levels were profiled over 24-hours to assess the effect(s) of constitutive 
overexpression of miR-142-3p (Fig. 7). In control miRNA transfected mPer2Luc SCN 
cultures, we observed robust rhythm in BMAL1 expression (p<0.001). The phase of 
BMAL1 protein was comparable to that of its mRNA with a peak protein expression, 
occurring around 20h after the final media change, being significantly (p<0.01) and ~3-
fold higher than the succeeding trough observed 8h later. In comparison, the BMAL1 
expression rhythm in miR-142-3p-transfected mPer2Luc SCN cultures was abolished 
(p>0.05). The rhythm disruption was accompanied by a steadily decreased over time 
(Fig. 7). At the time point (20h) associated with peak expression in control samples, 
corresponding levels of BMAL1 protein expression were significantly lower (p<0.05) in 
miR-142-3p transfected cultures. 
 
Discussion 
MiRNAs have recently garnered increased attention with regard to their 
contribution to regulation of circadian rhythms. Using diverse model systems, most 
studies have focused on miRNAs that are clock-controlled and function in the regulation 
of circadian output pathways. The primary observations of these studies suggest that 
miRNAs may play a role in the modulation of physiological and behavioral rhythms 
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 (Cheng et al., 2007; Gatfield et al., 2009; Kadener et al., 2009; Shi et al., 2009). In 
addition, there is some evidence indicating that clock-controlled miRNAs may also 
modulate clock input pathways. In this regard, the findings of Cheng et al. (2007) 
demonstrate that light-regulated and clock-controlled miRNAs in the mouse SCN are 
capable of altering membrane excitability and hence, may modulate input to the SCN 
circadian clock. However, it is yet unclear whether miRNAs regulate specific clock 
genes and contribute to the feedback modulation of core elements of the circadian 
clockworks. This is the first study identifying miR-142-3p as a clock-controlled miRNA 
that can modulate Bmal1 expression in the mouse SCN. Specifically, our findings 
indicate that miR-142-3p is expressed rhythmically in the mouse SCN in vivo and in an 
immortalized SCN cell line. Site-directed mutagenesis indicated that miR-142-3p targets 
the Bmal1 3’ UTR at two locations. We further show that constitutive overexpression of 
miR-142-3p abolishes rhythms in BMAL1 protein accumulation in an SCN cell line. 
Because rhythmic expression is a pervasive characteristic of core and ancillary 
elements involved in the circadian clock mechanism, we used bioinformatics analyses to 
identify evidence of rhythmic transcription of two putative Bmal1 targeting miRNAs, 
miR-142-3p and miR-494. E-box (CANNTG) elements are the sites of action for the 
CLOCK-BMAL1 heterodimer complex which results in rhythmic transcription of target 
genes (Shigeyoshi et al., 1997). In the present study, a conserved, canonical E-box 
element was identified ~1.5kb upstream of the miR-142 locus, indicating that this 
miRNA may be subject to circadian regulation by the core clock machinery. Although 
we did not verify the necessity of this E-box, a recent report by Tan et al., (2012) utilized 
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 ChIP and luciferase reporter assays to demonstrate that in NIH/3T3 cells CLOCK-
BMAL1 heterodimers bind to the E-box element and drive transcription of miR-142-3p.  
Temporal analysis identified rhythmic expression of mature miR-142-3p in the 
SCN, both in vivo and in mPer2Luc SCN cells in vitro. It is interesting that in the SCN in 
vivo, the peak phase of circadian miR-142-3p expression occurred during the early 
subjective day at ~CT3, several hours in advance of the peak in Per2 mRNA levels at 
~CT11 (data not shown). This phase relationship is similar to that observed between 
mature miR-219 and Per2 mRNA rhythm in the mouse SCN. Importantly, miR-219 was 
also previously shown to be a circadian clock-regulated gene (Cheng et al., 2007). A 
similar phase difference of ~8h between miR-142-3p and Per2 was also observed in the 
Per2Luc SCN cells in vitro (data not shown). The lack of rhythmic variation in the 
expression of both, miR-142-3p and Bmal1, in Per1ldc / Per2ldc SCN cultures provides 
further evidence that miR-142-3p is a bona-fide clock-regulated gene. 
The anti-phasic relationship between rhythmic miR-142-3p and Bmal1 
expression is also consistent with its role as a post-transcriptional repressor of Bmal1. To 
address whether the in vitro site-directed mutagenesis results for miR-142-3p-mediated 
repression of the Bmal1 3’ UTR extended to its functional activity in repression of 
endogenous BMAL1 protein levels, miR-142-3p was constitutively overexpressed in 
mouse mPer2Luc SCN cells. Overexpression of miR-142-3p abolished the rhythm in 
BMAL1 protein expression in these cells, indicating that this miRNA is involved in the 
regulation of endogenous BMAL1 protein levels. It is interesting that BMAL1 protein 
levels decline over time in miR-142-3p-transfected cells. This effect may reflect a 
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 combination of protein turnover and inhibition of translation by miR-142-3p due to its 
continuous production via the transfected pEZX-MR04 miRNA expression vector. 
Additionally, miRNAs can function as master switches, controlling expression of 
hundreds of genes (Lewis et al., 2005). In this regard, it is interesting that miR-142-3p 
has previously been shown to modulate cAMP levels by targeting adenylate cyclase 9 in 
T-cells (Lewis et al., 2005; Huang et al., 2009). This putative target for modulation by 
miR-142-3p is intriguing because cAMP, through its function as a second messenger, is 
involved in regulating the SCN circadian clock (Prosser and Gillette, 1989; O’Neill et 
al., 2008). Hence, miR-142-3p could potentially influence circadian physiology by 
regulating not only a core clock gene like Bmal1 but also circadian outputs like cAMP 
that may feed-back as input into the clock mechanism to fine-tune and/or sustain clock 
function. 
It is noteworthy that mature miR-142-3p is highly conserved in multiple 
vertebrate taxa. Also, the first miR-142-3p recognition element on mouse Bmal1 3’ UTR 
is conserved only among mammalian lineages while the second MRE is highly 
conserved across vertebrates. Hence, our data indicate that miR-142-3p might have 
important functional implications in the regulation of Bmal1 expression and the core 
molecular clockworks across multiple taxa. Additionally, because Bmal1 is expressed in 
cells and tissues throughout the body, miR-142-3p may also have an important role in 
circadian timekeeping function in central as well as in peripheral clocks (Yamamoto et 
al., 2004).  
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 CHAPTER III 
EXPRESSION AND RHYTHMIC MODULATION OF CIRCULATING 
MICRORNAS TARGETING THE CLOCK GENE Bmal1 IN MICE* 
 
Introduction 
MicroRNAs are small non-coding RNAs that have been identified in many 
different organisms ranging from Drosophila to humans (Bartel, 2004) and implicated in 
the regulation of a wide array of biological processes. Mature miRNAs are small RNA 
molecules, typically 19-25 nucleotides long, derived from sequential RNase III-
dependent cleavages of longer transcripts (Bernstein et al., 2001; Lee et al., 2003). In the 
cytoplasm, mature miRNAs associate with components of the RNA-induced Silencing 
Complex (RISC) and interact with miRNA-recognition elements (MRE’s) in the 3’ 
UTRs of target mRNAs. Mismatches or gaps in the base-pairing interactions between the 
miRNA-mRNA duplex result in translational repression and/or mRNA de-stabilization 
(Hutvagner and Zamore, 2002; He and Hannon, 2004). In humans, it has been estimated 
that the number of unique miRNAs exceeds 1000 (Perera and Ray, 2007) and that 20-
30% of the transcriptome is subject to miRNA-targeted regulation (Lewis et al., 2005; 
Xie et al., 2005).  
 
*Reprinted from “Shende VR, Goldrick MM, Ramani S and Earnest DJ (2011) 
Expression and rhythmic modulation of circulating microRNAs targeting the clock gene 
Bmal1 in mice. PLoS ONE 6:e22586”. Creative Commons Attribution License (CCAL). 
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 Although miRNAs target and regulate specific mRNA transcripts via 
intracellular mechanisms, recent evidence for their presence in vesicles circulating in the 
blood of humans (Mitchell et al., 2008) raises the possibility that miRNAs may also 
function as extracellular or secreted regulatory signals that mediate communication 
between cells (Thery et al., 2009). In accord with their role in modulating the 
transcriptome and proteome, miRNAs play an integral role in important biological 
processes like development, metabolism and cancer biology.  
Recent studies have also implicated miRNAs in the regulation of the circadian 
timekeeping mechanism in the mammalian suprachiasmatic nuclei (SCN). Brain, muscle 
ARNT-like protein 1 (Bmal1), circadian locomotor output cycles kaput (Clock), as well 
as the Period (Per1 and Per2) and Cryptochrome (Cry) genes comprise the “gears” of 
the molecular clockworks common to both the SCN and peripheral tissues (Shearman et 
al., 1997; Zylka et al., 1998; Yamazaki et al., 2000). Interactions between these clock 
components form positive- and negative-feedback loops in which gene transcription is 
rhythmically regulated by their protein products, with exception of Clock. For example, 
rhythmic increases in Bmal1 transcription and the formation of CLOCK-BMAL1 
heterodimers positively regulate the rhythmic transcription of the Per and Cry genes 
(Takahashi et al., 2008). In turn, the increases in PER and CRY proteins lead to the 
formation of heterodimers that interact with the CLOCK-BMAL1 complex and 
negatively feedback on their own transcription. CLOCK-BMAL1 complexes also 
mediate the regulation of clock-controlled outputs that provide for the rhythmic 
programming of downstream processes. MiRNA function in SCN-mediated regulation 
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 of circadian rhythms is supported by observations indicating that miR-219 and miR-132 
are rhythmically expressed in the SCN and that antagonism of these miRNAs within the 
SCN region respectively increases the circadian period of behavioral rhythmicity and 
attenuates circadian photoentrainment (Cheng et al., 2007). Other applications of mouse, 
Drosophila and chicken models provide further evidence for the role of miRNAs in the 
regulation of circadian rhythms in gene expression or behavior (Gatfield et al., 2009; 
Kadener et al., 2009; Shi et al., 2009). However, evidence for the role of specific 
miRNAs as bona fide modulators of core clock genes is limited.  
Because rhythmicity is a prevalent property among core and regulatory elements 
of the circadian clockworks in most cells and tissues throughout the body, we explored 
the possible timekeeping function of miRNAs in the periphery by initially determining 
whether specific miRNAs with clock genes as predicted targets are expressed in serum 
and whether their expression is marked by daily fluctuations. Our analysis focused on 
miRNAs that are predicted to target the 3’ UTR of Bmal1 mRNA because this clock 
gene is unique among core clock elements as knockout of Bmal1 alone produces 
complete loss of circadian rhythmicity (Bunger et al., 2000). Specifically, experiments 
were conducted to explore miRNA function in the circadian clockworks by: 1) first 
identifying miRNAs predicted to target core and ancillary clock genes; 2) determining 
whether expression of specific miRNAs that target Bmal1 oscillate in mouse serum in 
vivo; 3) examining the effects of candidate miRNA overexpression on Bmal1 3’ UTR 
activity; and 4) determining whether mutagenesis of specific target sites abates miRNA-
induced repression.  
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 Materials and Methods 
Experiment 1- Temporal Profiling of miRNA levels in mouse serum: Temporal 
profiling was performed to identify potential rhythms in circulating miRNA expression.  
Animals: Experimental subjects were 20 male Balb/C mice at 8–10 weeks of age. 
All animals were born and reared in the animal facility at BIOO Scientific under a 
standard 12h light:12h dark photoperiod (LD 12:12; lights-on at 0700 hr). Prior to 
experimental analysis, animals were housed 2-3 per cage.  Access to food and water was 
provided ad libitum and periodic animal care was performed at random times.  
Ethics Statement: All animal procedures used in this study were conducted in 
compliance with protocol B002 as approved by the Institutional Animal Care and Use 
Committee at BIOO Scientific Corp. 
Blood collection and fractionation: To determine whether miRNAs are expressed 
and fluctuate rhythmically in the serum, blood samples were collected at 4 hour intervals 
from mice maintained in a LD 12:12 cycle. At each timepoint, blood was collected by 
cardiac puncture from 3-4 mice that were anesthetized with 2,2,2-tribromoethanol (250 
mg/kg, intraperitoneal; Sigma) and sacrificed by cervical dislocation. Sampling 
procedures during the dark phase of the LD 12:12 cycle (Zeitgeber Time [ZT] 12-24) 
were conducted under dim red light (Kodak filter GBX-2). Blood was allowed to clot at 
room temperature for 10-15 minutes. Adhesions between the clot and collection tube 
were gently detached by "rimming the clot" to minimize hemolysis and then samples 
were centrifuged for 10 minutes in a swinging bucket microcentrifuge (Eppendorf) at 
3,000 x g to separate cellular and non-cellular fractions. Immediately following 
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 centrifugation, the serum layer was carefully aspirated off, mixed with three equivalent 
volumes of TRI reagent (Ambion) and stored at -20ºC until further processing. 
To fractionate the white blood cells (WBCs), the clot was disaggregated in 
phosphate buffered saline (PBS) and the fluid layer containing suspended WBCs and red 
blood cells (RBCs) was collected. Following centrifugation for 30 seconds at 3,000 x g, 
the cell pellet was resuspended in distilled water for ~10 sec to lyse RBCs by osmotic 
shock, and then mixed with 10X PBS to restore physiological ionic strength and prevent 
WBC lysis. The WBC pellet was recovered by centrifugation at 3,000 x g for 40 sec, 
lysed in 1 ml BiooPure RNA Isolation Reagent (BIOO Scientific, Austin, TX) and stored 
at -20ºC until further processing. 
RNA extractions: Total RNA was subsequently extracted from the serum and 
WBC lysates according to manufacturer’s protocols, with the exception that 50ug of 
linear acrylamide was added as a co-precipitant to the aqueous phase before addition of 
isopropanol. This modification enhances recovery of the small amounts of nucleic acids 
(Bartram et al., 2009). RNA samples were suspended in 50ul 0.1mM EDTA and 
dissolved by heating for 5 min at 65ºC. Total RNA was estimated using Nanodrop 
ND2000 (Thermo Scientific).  
Real-time PCR: Quantitative real-time PCR analysis was conducted using 
Taqman microRNA assays (Applied Biosystems). RNA from individual samples was 
first reverse transcribed using target-specific stem-loop primers and Taqman MicroRNA 
Reverse Transcription Kit. All assays were performed according to manufacturer’s 
protocols, using 20ng of total RNA as input with the exception that 90ng input RNA was 
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 used for reverse transcription of miR-494. For analysis of miRNA expression, the cDNA 
equivalent of 2ng of total RNA was PCR amplified in an ABI PRISM 7500 Fast 
sequence detection system using the following standard conditions: 1) heating at 95ºC 
for 10 min, and 2) amplification over 40 cycles at 95ºC for 15 sec and 60ºC for 1 min. 
This analysis was conducted concurrently on duplicate aliquots of RT product from each 
sample. miR-16 was also amplified from the same samples using identical parameters to 
control for differences in sample RNA content and reverse-transcription efficiencies 
because: 1) this miRNA has provided a good standard for normalization and 
comparisons of relative abundance in previous studies (Venturini et al., 2007; Kroh et 
al., 2010); and 2) ANOVA analysis indicates that miR-16 levels in the serum exhibit no 
significant variation (p = 0.19) over the 24-hour time course for sampling (data not 
shown). Using the comparative CT method described in the ABI Prism 7700 Sequence 
Detection System User Bulletin #2 (PE-ABI), the relative abundance for a given miRNA 
was calculated by normalization first to corresponding miR-16 levels in each sample and 
then to a calibrator consisting of pooled cDNA from multiple samples over the entire 
time series. All TaqMan miRNA assays used in this study exhibited PCR efficiencies of 
95-101.6%. 
Relative quantification of 18s rRNA abundance was performed on some serum 
and WBC samples using SYBR-Green real-time PCR technology (ABI) as described 
previously (Allen et al., 2004; Farnell et al., 2008). To generate single-strand cDNAs, 
total RNA (250ng) from individual samples was reverse transcribed using random 
hexamers and Superscript III reverse transcriptase (Invitrogen).  18s rRNA was PCR 
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 amplified using the cDNA equivalent of 2.5ng of total RNA. PCR analysis was 
performed on duplicate aliquots of each sample using the ABI PRISM 7500 Fast 
sequence detection system and the following conditions: 1) serial heating at 50ºC for 2 
min and 95ºC for 10 min, 2) amplification over 40 cycles at 95ºC for 15 sec and 60ºC for 
1 min, and 3) dissociation at 95ºC for 15 sec, 60ºC for 1 min, 95ºC for 15 sec and 60ºC 
for 15 sec. Relative differences in 18s rRNA abundance were established by comparing 
serum and WBC determinations to a standard curve that was generated using pooled 
cDNA from all samples. The following primers were used for the real-time PCR 
analysis: m18s rRNA forward: 5'-ATGGCCGTTCTTAGTTGGTG -3'; m18s rRNA 
reverse: 5'-CGCTGAGCCAGTCAGTGTAG -3'. 
To estimate the number of copies of representative miRNAs in serum samples, 
synthetic single-stranded RNA oligonucleotides encoding the mature miRNA sequences 
for miR-16 and miR-152 were purchased from Integrated DNA Technologies, Inc. 
Mature miRNA sequence information was procured from miRBASE (release 16.0; Sept. 
2010). These synthetic miRNAs were used in a dilution series ranging from 1 
molecule/µl to 1010 molecules/µl to generate standard curves for quantification of 
molecules of miR-16 and miR-152. Standard curves derived from concentrations 
yielding Ct values within the linear range were used to estimate number of copies of 
miR-16 and miR-152 in the input RNA from ZT7 serum samples that were 
simultaneously reverse-transcribed, PCR-amplified and analyzed on the same plate. 
Absolute copy number of miRNAs per microliter of serum was extrapolated using 
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 known information on the amount of input RNA (10ng) and total extracted RNA (1500-
4500ng) relative to the specific volume collected (200-300µl) for each serum sample.  
Experiment 2- MiRNA regulation of Bmal1 3’ UTR activity: Timekeeping 
function of circulating miRNAs was investigated by 3’ UTR reporter activity assays.  
Bmal1 3' UTR luciferase reporter construct: miTarget™ miRNA Target 
Sequence 3' UTR Expression Clone for Bmal1 was purchased from Genecopoeia. This 
expression clone contains Bmal1 (Accession: NM_007489.3) 3’ UTR sequence inserted 
in the pEZX-MT01 vector downstream of a firefly luciferase gene under the control of 
an SV40 enhancer generating a chimeric transcript that consists of the luciferase coding 
and Bmal1 3’ UTR sequences. The pEZX-MT01 vector also contains the Renilla 
luciferase gene under the control of a CMV promoter to provide for dual analysis of 
firefly and Renilla luciferase activities in individual samples and to normalize firefly 
luciferase signal intensities and account for potential differences in transfection 
efficiencies across control and experimental cultures. To determine the specificity of 
miRNA interactions with the Bmal1 3' UTR, similar analyses were performed using 
miRNA Target clone control vector (Genecopoeia; CmiT000001-MT01) which consists 
of the pEZX-MT01 vector without a 3' UTR tagged to the firefly coding sequence. 
miTarget™ miRNA Target Sequence 3' UTR Expression Clone encoding the cKit 3' 
UTR (Accession: NM_021099.2; generously provided by Dr. Rajesh Miranda, Texas 
A&M University Health Science Center) was also used as an additional control. Based 
on the results from Targetscan analysis, the cKit 3’ UTR is predicted to contain a target 
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 site for miR-494, but not for miR-142-3p or miR-152. The cKit 3’ UTR also contains a 
predicted target site for miR-142-5p, the antisense transcript of miR-142-3p. 
Transformed E. coli cells (Genecopoeia) were grown on kanamycin (final conc. 
= 50ug/ml) containing imMedia agar plates (Invitrogen). A single isolated colony was 
propagated in imMedia Kan+ (final conc. = 50ug/ml) liquid medium and plasmid was 
extracted using EndoFree Plasmid Maxi kit (Qiagen). The extracted pEZX-MT01 Bmal1 
3’ UTR expression plasmid was sequenced to verify expression and accuracy of the 
Bmal1 3’ UTR sequence using the following primers: Forward:  5'-
GATCCGCGAGATCCTGAT-3'; Reverse:  5'-TTGGCGTTACTATGGGAACAT-3'. 
Similar procedures were followed for isolation of the pEZX-MT01 control vector and 
the pEZX-MT01 cKit 3’ UTR expression vector.  
Cell culture and transfections:  Human embryonic kidney cells (HEK 293) at 
passage 12-15 were used for experimental analysis of miRNA regulation of Bmal1 3’ 
UTR activity. Cells were seeded on 60-mm cell culture dishes (Corning) and maintained 
at 37ºC and 5% CO2 in Dulbecco’s minimum essential medium (DMEM; Invitrogen) 
without antibiotics and supplemented with 10% Fetal Bovine Serum (FBS; HyClone, 
Logan, UT) and 292ug/mL L-glutamine. Medium was changed at 48-hour intervals and 
confluent cultures were split 1:4 or 1:5 every 3-4 days. Prior to experimentation, cells 
were seeded onto 24-well plates in DMEM supplemented with 5% FBS. 24 hours later, 
co-transfection of verified plasmid DNA clones (0.4ug) with either individual pre-miRs, 
or paired combinations of pre-miR constructs for miR-494, miR-152, or miR-142-3p 
(final conc. 33nM/well; ABI) was performed using Lipofectamine 2000 (Invitrogen) 
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 according to the manufacturer’s protocols. To compare basal luciferase reporter activity 
across different pEZX-MT01 vectors and evaluate the potential influence of endogenous 
miRNAs, parallel analysis was performed on HEK 293 cells in which either the pEZX-
MT01 control vector or the Bmal1 3’ UTR vector was co-transfected with a non-
targeting control miRNA. Following incubation with transfection reagents for 5 hours, 
the medium was replaced and 48 hours later, lysates of HEK293 cultures from all 
treatment groups (n=4) were collected using Passive Lysis Buffer (Promega). Lysate 
samples were stored at -20ºC and later firefly luciferase activity was analyzed relative to 
Renilla luciferase activity in the same sample using dual-luciferase reporter assay system 
(Promega). Luminescence was measured in counts per second using a LumiCount 
microplate luminometer (AL10000; Packard Bioscience). 
Bmal1 3′ UTR site-directed mutagenesis: miTarget™ miRNA Target Sequence 
3′ UTR Expression Clone containing Bmal1 3’ UTR sequence (Accession: 
NM_007489.3) inserted in the pEZX-MT01 vector was purchased from Genecopoeia, 
Inc. The plasmid was propagated using methods established in our previous study 
(Shende et al., 2011). Deletions in miR-142-3p binding sites on the Bmal1 3’ UTR were 
generated using QuikChange II XL Site-Directed Mutagenesis Kit (Stratagene Inc.) 
according to the manufacturer’s protocols. Briefly, the full-length mBmal1 3’ UTR was 
PCR mutagenized using specific primers so as to delete nucleotides 1-7 complementary 
to miR-142-3p seed region. After Dnp1-mediated degradation of parental plasmid DNA, 
the mutagenized plasmid was transformed into XL10-Gold Ultracompetent cells 
(Stratagene, Inc.) and transformants were selected on kanamycin-containing (final conc. 
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 = 50ug/mL) imMedia agar plates (Invitrogen, Inc.). A single colony was isolated and 
propagated in imMedia Kan+ liquid medium (final conc. = 50ug/mL). The plasmid was 
extracted using HiSpeed Plasmid Midi Kit (Qiagen, Inc.) and then sequenced to verify 
the targeted deletion (Bmal1 c.1_7del). The same methods were also used to delete 
nucleotides 335-357 corresponding to a second miR-142-3p target site on the full-length 
Bmal1 3’ UTR. This plasmid (Bmal1 c.335_357del) was then subjected to a second 
round of mutagenesis to provide for additional deletion of nucleotides 1-7. The plasmid 
with targeted deletions of both miR-142-3p target sites on the mBmal1 3’ UTR (Bmal1 
c.1_7del + c.335_357del) was propagated and sequenced to verify these deletions as 
described above. The miRNA 3′ UTR target control vector (Genecopoeia; CmiT000001-
MT01), consisting of the pEZX-MT01 vector backbone without any 3’ UTR sequence, 
was used to determine the specificity of miRNA interactions with the full-length and 
mutagenized mBmal1 vectors. miR-142-3p-mediated regulation of mBmal1 3’ UTR was 
analyzed in human embryonic kidney (HEK293) cells using established methods 
(Shende et. al., 2011). Briefly, cells were seeded onto 24-well plates (Corning, Inc.) and 
24h later were co-transfected with miR-142 expression vector (miExpress Precursor 
miRNA expression clone; Genecopoeia, Inc., MmiR3437-MR04) and with either the 
target control, mBmal1, Bmal1 c.1_7del, Bmal1 c.335_357del or Bmal1 c.1_7del + 
c.335_357del miRNA 3’ UTR clone. As an additional control for specificity of the 
deletion, cells were also co-transfected with miR-494 expression vector and either the 
target control, mBmal1 or Bmal1 c.1_7del + c.335_357del miRNA 3’ UTR clone. 
Following transfection for 5 hours, cells were rinsed and the medium was replaced. 
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 Forty-eight hours later, cell lysates of HEK293 cultures from all treatment groups (n= 4) 
were prepared using Passive Lysis Buffer (Promega, Inc.). Firefly and Renilla luciferase 
activity from individual samples was then analyzed using the dual-luciferase reporter 
assay system (Promega, Inc.). Luminescence was measured on Synergy2 microplate 
luminometer (Biotek Inc.) and reported as the ratios of firefly luciferase signal 
normalized to Renilla luciferase activity in the same sample. 
Statistical analyses: The temporal patterns of miRNA expression in serum were 
examined for evidence of circadian variation using statistical analyses that have been 
used previously for this purpose (Allen et al., 2001; Menger et al., 2005; Menger et al., 
2007). Time-dependent fluctuations in miR-494, miR-152 and miR-142-3p expression 
were first identified by one-way analysis of variance (ANOVA). Paired comparisons 
between peak values and those observed during the preceding or succeeding minimum 
were analyzed post hoc for statistical differences using the Newman-Keuls sequential 
range test. The α-value was set at 0.05 for these post hoc analyses. Independent t-tests 
were performed on serum and WBC 18s and miRNA comparisons, and on normalized 
luminescence data to determine the significance of pre-miR and control-miR treatment 
on luciferase-reported Bmal1 3' UTR activity. The α-value was set at 0.01 for 
independent t-tests. 
 
Results 
Experiment 1- Temporal Profiling of miRNA levels in mouse serum: Three 
target prediction databases (microcosm (Griffiths-Jones et al., 2006; Griffiths-Jones et 
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 al., 2008), Targetscan (Lewis et al., 2005) and MiRanda (John et al., 2004)) were used to 
identify potential miRNAs targeting mammalian clock genes. Because Bmal1 is the only 
clock gene in which null mutation produces arrhythmicity (Bunger et al., 2000), we 
focused on a subset of miRNAs that express consensus recognition sequences for the 3’ 
UTR of either Bmal1 or for other genes that regulate Bmal1 expression in the molecular 
feedback loops comprising the circadian clockworks (Table 1). The Bmal1 3’ UTR was 
predicted to contain miR-152, miR-142-3p and miR-494 target sites that are located at 
nucleotide positions 88-108, 335-357 and 473-495, respectively. It is interesting that in 
addition to their putative targeting of the Bmal1 3’ UTR, miR-152 and miR-494 were 
also predicted to interact with its primary partner Clock or with transcriptional activators, 
retinoic acid-related orphan receptors alpha and beta (Rorα, Rorβ).  
 
  
Table1. Application of target prediction programs to identify candidate miRNAs 
expected to target Bmal1 or other genes that regulate Bmal1 expression. 
 MicroCosm TargetScan MiRanda 
mmu-miR-142-3p Bmal1 Bmal1 Bmal1 
mmu-miR-152 Bmal1, Rorβ - Bmal1, Rorα, Rorβ 
mmu-miR-494 Bmal1, Rorβ Bmal1, Clock, Rorβ Bmal1, Per2, Rorβ 
mmu-miR-135b - - Rorα, Rorβ 
mmu-miR-135a - - Rorα, Rorβ 
mmu-miR-34c Reverbα - Per2 
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 We next determined whether any of the identified miRNAs predicted to target 
Bmal1 or other components of the clock feedback loops were expressed in serum. All of 
the candidate miRNAs were detected in serum during the daytime of LD 12:12 cycle 
(ZT 7), but their circulating levels spanned a wide range. miR-142-3p, miR-152, miR-
494, miR-135b, miR-135a and miR-34c were found in descending order of abundance in 
the serum (Fig. 8A). Consistent with previous observations on its circulating levels in 
humans (Mitchell et al., 2008), miR-16 was highly abundant relative to other miRNAs 
detected in mouse serum. Quantitative analysis of miR-16 and miR-152 levels revealed 
that the estimated concentrations of these miRNAs were 408,000-749,000 and 3,400-
6,800 copies/µl serum (Fig. 8B), respectively. Using this information as a relative index 
of abundance, miR-142-3p, miR-152 and miR-494 appear to represent species of 
moderate to low expression in serum. To gauge the relationship between serum and 
cellular miRNA levels, we also analyzed the WBC fractions of individual blood samples 
for expression of specific miRNAs predicted to target Bmal1.  
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Figure 8. Comparison of circulating miRNAs predicted to target Bmal1 or other genes 
regulating Bmal1 expression with a highly abundant miRNA in serum. (A) Relative 
expression of miR-16, miR-142-3p, miR-152, miR-494, miR-135b, miR-135a and miR-
34c in serum samples collected from mice at ZT 7 (n=3). Bars denote real-time PCR 
determinations of serum miRNA levels (mean ± SEM) and the values are plotted using a 
logarithmic scale in comparison with the average for miR-34c expression. (B) 
Quantification of miR-16 and miR-152 expression in serum collected from mice at ZT 7 
(n=3). Symbols denote determinations (in duplicate) of the number of copies/µl serum in 
each sample that were extrapolated by comparing the Ct values for experimental samples 
with standard curves consisting of a dilution series of known quantities of synthetic miR-
16 and miR-152 analyzed on the same plate. 
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 These components of blood exhibited variable differences in miRNA levels such 
that miR-142-3p and miR-494 expression were lower (77-fold and 1.5-fold, 
respectively) and miR-152 was higher (25-fold) in serum than in WBCs (Fig. 9A). The 
differential expression of miR-142-3p in WBCs is not surprising because this miRNA is 
highly abundant in hematopoietic cell lineages (Merkerova et al., 2008). Because recent 
findings indicate that despite their abundant expression in the cytoplasm 18s and 28s 
rRNA are absent in RNA extracted from circulating exosomes (Valadi et al., 2007), 18s 
rRNA levels were analyzed in serum and WBC fractions of blood samples collected 
from mice (n=3-4) at ZT3 and ZT7 to confirm that the detected small RNAs reflect 
serum expression, rather than artifact associated with cellular lysis during sample 
preparation. Consistent with the observations of Valadi et al. (2007), serum levels of 18s 
rRNA were negligible and at the limits of detection with real-time PCR analysis. 
Relative expression levels of 18s rRNA in the serum were 26,000-79,000-fold lower 
than those found in WBC fractions (Fig. 9B), indicating that the observed miRNA 
signals in serum are derived from extracellular or vesicle-encapsulated RNA, and not 
from lysed or intact leukocytes or other cells, in the blood samples. 
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Figure 9. Comparison of miRNA and 18s rRNA levels in the serum and corresponding 
white blood cell (WBC) fractions. (A) Bars denote real-time PCR determinations of 
serum and WBC miRNA levels (mean ± SEM) in blood samples collected from mice 
(n=3) at ZT 7. The plotted values correspond to the ratios of fraction-specific miR-142-
3p, miR-494 and miR-152 signal and are represented as a percentage of the maximal 
value obtained among the serum and WBC fractions. Asterisks denote comparisons in 
which the relative expression of miRNA signal in the WBC fraction was significantly 
different (p < 0.05) from that observed in serum samples. (B) Bars denote real-time PCR 
determinations of 18s rRNA levels (mean ± SEM) in serum and WBC fractions of blood 
samples collected from mice (n=3-4) at ZT 3 and ZT 7. The plotted values are 
represented as a percentage of the average for the WBC fraction at ZT 7. Asterisks 
denote time-specific comparisons (ZT 3 and ZT 7) of 18s rRNA signal in which relative 
expression in the WBC group was significantly greater (p < 0.01) than that observed in 
serum samples. 
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 Daily profiles of miRNA expression in serum were assessed to determine 
whether circulating levels of mature miRNAs that are predicted to target mouse Bmal1 
or other genes regulating this key component of the molecular clockworks, miR-494, 
miR-152 and miR-142-3p, oscillate rhythmically. In mice exposed to LD 12:12, diurnal 
fluctuations were observed in the relative expression of miR-494 and miR-152 
(normalized to miR-16) in the serum (Fig. 10). The rhythm in circulating levels of miR-
494 was marked by a bimodal pattern in which the first peak in serum expression 
occurred around mid-day at ZT 7 and was followed by a secondary peak during the night 
around ZT 19. For the diurnal oscillation in miR-494 expression, the bimodal peaks in 
serum levels at ZT 7 and ZT 19 were significantly (p < 0.05) and about 2- to 5-fold 
greater than those observed during the preceding and succeeding minima. Similar to the 
temporal profile for miR-494 expression, serum levels of miR-152 were characterized by 
diurnal variation with bimodal peaks (Fig. 10). The first zenith in miR-152 expression 
occurred again at ZT 7 and was followed by a secondary peak in mature miRNA levels 
at ZT 15. The amplitude of rhythmic miR-152 expression in the serum was robust, with 
2- to 8-fold differences between peak and trough values. The bimodal peaks in 
circulating levels of miR-152 at ZT7 and ZT15 were significantly greater (p < 0.05) than 
the preceding and succeeding minima. In contrast to other tested miRNAs, miR-142-3p 
levels in the serum exhibited no evidence of diurnal fluctuations (Fig. 10). In comparison 
with miR-494 and miR-152, serum levels of miR-142-3p were relatively high with no 
significant variation over time (p = 0.377). 
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Figure 10. Temporal patterns of miR-494, miR-152 and miR-142-3p expression in 
mouse serum. Symbols denote real-time PCR determinations of miRNA levels (mean ± 
SEM) in serum collected at 4-hour intervals from mice (n=3-4) during exposure to a LD 
12:12 cycle. The plotted values correspond to the ratios of miR-494 (top left), miR-152 
(top right) and miR-142-3p (bottom) signal normalized to miR-16 levels in each sample 
and are represented as a percentage of the maximal value obtained for each miRNA. 
Asterisks indicate time points during which peak values for serum expression of a given 
miRNA were significantly greater (p < 0.05) than those observed during preceding and 
succeeding minima. 
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 Experiment 2- miRNA regulation of Bmal1 3’ UTR activity: Since the observed 
circadian fluctuations in serum levels of miRNAs predicted to target Bmal1 is suggestive 
of their involvement in circadian timekeeping mechanisms, we used an in vitro reporter 
assay to examine the effects of miR-494, miR-152 and even miR-142-3p on Bmal1 
expression via targeting of the 3’ UTR of this clock gene. Bioluminescence was 
analyzed in HEK293 cells co-transfected with the pEZX-MT01 Bmal1 3’ UTR 
expression vector and pre-miR constructs for miR-494, miR-152, or miR-142-3p (n=4). 
To control for non-specific interactions between pre-miRs and the luciferase reporter in 
the pEZX-MT01 vector, parallel analysis was performed on HEK293 cells co-
transfected with these pre-miR constructs and the pEZX-MT01 control vector which 
does not contain a 3' UTR tagged to the firefly coding sequence (n=4). In HEK293 cells 
co-transfected with Bmal1 3’ UTR expression vector, overexpression of miR-494 or 
miR-142-3p, but not miR-152, produced significant decreases (p < 0.01) in luciferase-
mediated bioluminescence relative to that found in cells transfected with the control 
vector (Fig. 11A). Treatment with pre-miR constructs for miR-494 or miR-142-3p 
repressed Bmal1 3’ UTR-mediated bioluminescence by about 35% and 60%, 
respectively, in comparison with control transfections. Transfection with a non-targeting 
miRNA had no significant effect on luciferase-mediated bioluminescence in Bmal1 3’ 
UTR-expressing cells relative to that found in cells transfected with the control vector, 
suggesting that basal reporter activity is similar between the Bmal1 3’ UTR and control 
vectors and that the observed repression of the Bmal1 3’ UTR is specific for miR-494 
and miR-142-3p. 
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  Pre-miR interactions with the 3’ UTR of a non-clock gene containing predicted 
target sites for miR-494 but not miR-152 or miR-142-3p were explored by analyzing 
bioluminescence from HEK293 cells co-transfected with the pEZX-MT01 vector 
expressing the cKit 3’ UTR and pre-miR constructs for these miRNAs (n=4). Consistent 
with target prediction data indicating that the cKit 3’ UTR contains a predicted target site 
for miR-494, overexpression of miR-494 in pEZX-MT01 cKit 3’ UTR-transfected cells 
yielded a significant reduction (p < 0.01) in luciferase-reported bioluminescence relative 
to that observed in cells co-transfected with this pre-miR and the control vector (Fig. 
11A). In response to treatment with pre-miR constructs for miR-494, cKit 3’ UTR-
mediated bioluminescence was repressed by about 30% in comparison with luciferase 
reporter expression in cells co-transfected with the control vector. Importantly, treatment 
with pre-miR constructs for miR-152 had no significant effect in repressing luciferase-
mediated bioluminescence in cKit 3’ UTR-expressing cells.  In fact, overexpression of 
miR-152 in pEZX-MT01 cKit 3’ UTR-transfected cells produced a small increase in 
bioluminescence relative to that found in control vector-transfected cells. Interestingly, 
treatment with pre-miR constructs for miR-142-3p caused a significant increase in cKit 
3’ UTR-mediated bioluminescence relative to the luciferase activity of the control 
vector. The basis for this inductive effect of miR-142-3p on cKit 3’ UTR activity is 
unknown but the cKit 3’ UTR is predicted to contain a target site for miR-142-5p and 
overexpression of its antisense transcript, miR-142-3p, may effectively reverse any basal 
repression derived from interactions of endogenous miR-142-5p with the cKit 3’ UTR. 
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Figure 11. Independent and combinatorial effects of miR-494, miR-152 and miR-142-
3p overexpression on Bmal1 3’ UTR activity. Bars denote mean (±SEM) determinations 
of luciferase bioluminescence for each treatment group (n=4). The plotted values 
correspond to the ratios of firefly luciferase signal normalized to Renilla luciferase 
activity in the same sample and are represented as a percentage of the average signal for 
control vector transfectants. (A) Normalized bioluminescence from HEK293 cells 
expressing the pEZX-MT01 control vector, or pEZX-MT01 vector containing either cKit 
3’ UTR or Bmal1 3’ UTR in response to treatment with pre-miR constructs (33nM) for 
miR-494, miR-152 and miR-142-3p. (B) Normalized bioluminescence from HEK293 
cells expressing the pEZX-MT01 control vector or pEZX-MT01 vector containing the 
Bmal1 3’ UTR in response to treatment with paired combinations of these pre-miR 
constructs (33nM; miR-494+miR-152, miR-494+miR-142-3p, miR-152+miR-142-3p). 
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 Because previous studies indicate that two different miRNAs can act in concert 
to simultaneously repress translation of a single mRNA (Doench and Sharp, 2004), we 
next examined the combinatorial effects of miR-494, miR-152 and miR-142-3p 
overexpression in repressing Bmal1 3’ UTR activity. For all of the tested miRNA 
combinations (miR-494+miR-152, miR-494+miR-142-3p, miR-152+miR-142-3p), 
luciferase-reported bioluminescence was significantly reduced (p < 0.01) in Bmal1 3’ 
UTR-expressing cells relative to that control vector transfectants (Fig. 11B). 
Combinatorial effects in repressing luciferase-reported Bmal1 3’ UTR activity were 
lowest in response to miR-494 and miR-152 overexpression (~21%) and were highest in 
cells treated with pre-miR constructs for miR-494 and miR-142-3p (~75%). In 
conjunction with the observed differences in the repressive effects of individual 
miRNAs, these results suggest that among the tested transcripts, miR-142-3p is the most 
potent repressor of Bmal1 3’UTR-mediated activity. Moreover, the potentiated 
repression observed in response to combined treatment with pre-miR constructs for miR-
142-3p and miR-494 is compatible with previous evidence for the synergistic regulation 
of the 3’ UTR for a single gene by two or more miRNA species (Doench and Sharp, 
2004). Based on the independent and combinatorial effects of miR-494 on Bmal1 3’ 
UTR activity, our results support the possibility that oscillations in serum levels of this 
miRNA may contribute to local rhythms in the post-transcriptional repression of 
endogenous Bmal1 in the periphery.  
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Figure 12. Effects of miR-142-3p on luciferase reporter activity of Bmal1 wild-type or 
miR-142-3p MRE mutagenized 3′ UTR constructs. (A) Diagrammatic representation of 
WT and mutagenized Bmal1 3’ UTR constructs. (B & C) The plotted values correspond 
to the ratios (mean + SEM) of firefly luciferase signal normalized to Renilla luciferase 
activity in the same sample and are represented as a percentage of the average signal for 
control vector transfectants. Asterisks indicate observations where normalized 
bioluminescence values for treatment were significantly different from those observed 
for control. (B) Normalized bioluminescence from HEK293 cells expressing the pEZX-
MT01 control vector, or pEZX-MT01 vector containing either wild-type or mutagenized 
Bmal1 3′ UTR in response to treatment with pEZX-MR04 miRNA expression clone for 
miR-142-3p. (C) Normalized bioluminescence from HEK293 cells expressing the 
pEZX-MT01 control vector or pEZX-MT01 vector containing the Bmal1 3′ UTR in 
response to treatment with pEZX-MR04 miRNA expression clone for miR-494. 
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 Based on target prediction algorithms, the repression produced by miR-142-3p is 
predicted to occur via two consensus binding sites located at positions 1-7 and 335-357 
on the Bmal1 3’ UTR. To validate specificity and relative contribution of the two 
predicted target sites, independent and combinatorial site-directed mutagenesis of these 
loci was performed and an in vitro dual-luciferase reporter assay system was used to 
examine resultant effects on Bmal1 3’ UTR activity as described previously (Shende et 
al., 2011). Bioluminescence was analyzed in HEK293 cells co-transfected with pEZX-
MR04 miR-142 expression vector construct and pEZX-MT01 Bmal1 3′ UTR construct 
for either full-length Bmal1 (WT) or mutants with targeted deletions of nucleotides 1-7 
(c.1_7del), nucleotides 335-357 (c.335_357del) or both loci (c.1_7del + c.335_357del) 
(Fig. 12A). Consistent with its effects observed in our previous study (Shende et al., 
2011), miR-142-3p overexpression in HEK293 cells co-transfected with the WT Bmal1 
3′ UTR expression vector produced significant decreases (p<0.01) of ~60% in 
luciferase-reported bioluminescence relative to that found in cells transfected with the 
control vector. In comparison, overexpression of miR-142-3p in HEK293 cells co-
transfected with either the c.1_7del or c.335_357del Bmal1 3′ UTR expression vector 
produced significant (p<0.05) but diminished (~30%) reduction in luciferase-reported 
bioluminescence relative to that found in cells transfected with the control vector. 
Deletion of both 3’ UTR target sites (c.1_7del + c.335_357del) completely abolished 
miR-142-3p-mediated repression and there was no significant difference in 
bioluminescence from cells transfected with control vector or the c.1_7del + 
c.335_357del construct (p=0.33) (Fig. 12B). Our results thus validate miR-142-3p target 
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 predictions and indicate that both sites contribute equally to the action of miR-142-3p in 
the repression of the Bmal1 3’ UTR. 
In addition to miR-142-3p, miR-494 also represses the Bmal1 3’UTR activity by 
potentially interacting with nucleotides 473-495. Consequently, the effects of miR-494 
on Bmal1 3’UTR activity were analyzed to verify that the loss of repression observed 
with the Bmal1 c.1_7del + c.335_357del construct was specific to the action of miR-
142-3p. In HEK cells co-transfected with this mutant 3’ UTR construct, overexpression 
of miR-494 caused significant reduction (p<0.01) of ~35% in luciferase-reported 
bioluminescence relative to cells co-transfected with the control vector (Fig. 12C). 
Importantly, this repression of Bmal1 3’ UTR activity was similar to that observed for 
the WT construct, suggesting that the two analyzed loci are specific targets for the action 
of miR-142-3p. 
 
Discussion 
 Circulating levels of many humoral factors, including insulin, adrenalin, leptin, 
ghrelin and corticosterol, are marked by robust circadian rhythmicity (Tasaka et al., 
1980; De Boer and Van der Gugten, 1987). These hormones and neuroendocrine factors 
are thought to play a role in the hierarchical organization of the mammalian circadian 
system with regard to the coordination of rhythmicity between peripheral and CNS 
oscillators (Hommel et al., 2006; LeSauter et al., 2009). Although there is now 
increasing evidence for the presence of circulating miRNAs and their potential 
implications as biomarkers of pathological and physiological states (Gilad et al., 2008; 
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 Hunter et al., 2008; Mitchell et al., 2008), the current study provides primary evidence 
indicating that levels of some circulating miRNA species are subject to rhythmic 
regulation as well. Specifically, our findings indicate that several miRNAs predicted to 
target core clock genes are also expressed in mouse serum, and that circulating levels of 
miR-494 and miR-152 are distinguished by diurnal oscillations.  Similar to other diurnal 
and circadian rhythms in various processes including arterial pressure, neurotransmitter 
receptors, and circulating levels of hormones (Lucas et al., 1980; Wirz-Justice et al., 
1987; Li et al., 1999), serum levels of miR-494 and miR-152 oscillate with bimodal 
patterns. Hughes et al. (2009) identified similar 12h harmonics of expression of multiple 
genes in vivo. The harmonics were lost ex vivo, and only a single circadian peak was 
observed. Thus, some bi-modal (12h harmonic) rhythms, including those observed in 
circulating miRNAs may reflect the independent contribution of two uncoupled 
oscillators representing system driven and oscillator dependent rhythms. It is noteworthy 
that despite the similarity in the phase of their rhythmic profiles with bimodal peaks 
occurring near mid-day and during the night, miR-494 and miR-152 are transcribed at 
different loci in the mouse genome; both are transcribed from a single locus, on 
chromosome 11 for miR-152 and on chromosome 12 for miR-494. Another distinction is 
that miR-152 is an intronic miRNA, while miR-494 is part of a large cluster.  
 The mechanism responsible for the rhythmic variations in serum levels of miR-
494 and miR-152 is unknown. Importantly, comparative analysis of 18s rRNA levels in 
serum and corresponding WBC samples suggests that the miRNA expression and 
rhythmic profiles detected in serum are not contamination or artifact derived from lysed 
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 or intact cells in the circulation. The observed rhythms in circulating levels of miR-494 
and miR-152 may correspond to temporal variation in the intracellular production, 
packaging or endocytic trafficking of these miRNAs and/or their uptake by specific 
target cells. Alternatively, it is possible that the differential stability of some circulating 
miRNAs over time may contribute to these serum oscillations.  
 Recent evidence suggests that miRNAs may act as molecular switches regulating 
the timing of various biological events (Bartel and Chen, 2004). Thus, the present 
implications for miRNAs in circadian timekeeping seem to represent a logical extension 
of their known functions. At present, the precise role of miRNAs in either the molecular 
clockworks or the hierarchical organization of mammalian circadian oscillators is 
unclear. Several reports indicate that miRNAs may modulate some aspects of circadian 
pacemaker function and output rhythms (Cheng et al., 2007; Gatfield et al., 2009). Using 
in vitro analysis of luciferase-reported Bmal1 3’ UTR activity to examine the effects of 
miRNA overexpression, miR-494 and miR-142-3p were identified as potential post-
transcriptional repressors of Bmal1, for the first time implicating specific miRNAs in the 
regulation of this integral molecular component of the mammalian circadian clock. We 
also validated specific sites in the 3’ UTR responsible for miR-142-3p action. 
Nucleotides 1-7, which are conserved in the Bmal1 3’ UTR among mammalian lineages, 
are 100% complementary to the seed region (nucleotides 2-8) of miR-142-3p (Lewis et 
al., 2005). The activity of a miRNAs is primarily thought to be dependent on 
complementarity between 3’ UTR elements of target mRNA and the seed region of the 
candidate miRNA. Indeed, in vitro reporter assays indicate that 7-8mer sites 
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 complementary to seed region of candidate miRNAs are sufficient for miRNA-mediated 
repression of the target 3’ UTRs (Doench and Sharp, 2004; Brennecke et al., 2005; Lai 
et al., 2005). In corroboration with this presumed importance of seed region interactions, 
deletion of the first seven nucleotides in the Bmal1 3’ UTR abated miR-142-3p mediated 
repression by ~50%, indicating that miR-142-3p targets this specific sequence. 
Additionally, we also examined miR-142-3p interactions with a highly conserved, 
canonical miRNA recognition element (MRE) located from positions 335-357 of the 
mBmal1 3’ UTR. This site contains a 8mer element perfectly complementary to the seed 
region of miR-142-3p. In addition to the importance of the seed region, positions 13-19 
of mature miRNA strands may also aid in the biological activity of miRNAs by 
functioning as 3’ supplementary or 3’ compensatory regions (Brennecke et al., 2005; 
Yekta et al., 2004; Grimson et al., 2007). Hence, all 22 nucleotides constituting the 
canonical MRE were deleted to accurately analyze miR-142-3p interactions with this 
target site. This deletion also yielded a ~50% reduction in miR-142-3p-mediated 
repression of Bmal1 3’ UTR activity compared to non-mutagenized controls. Site-
directed deletion of both miR-142-3p target sites, at nucleotides 1-7 and 335-357, 
completely abolished miR-142-3p mediated repression of the Bmal1 3’ UTR activity. 
Comparable miR-494-mediated repression of the full-length (WT) and c.1_7del + c.335-
_357del Bmal1 3’ UTR clones verified that the deletions were in sites specifically 
required for miR-142-3p action. Thus, the mutagenesis analyses for the first time 
indicate that the Bmal1 3’ UTR is targeted by miR-142-3p at two distinct locations and 
that both sites contribute equally to the repression produced by miR-142-3p. 
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  The phase relationship between the diurnal rhythms in circulating levels of miR-
494 and Bmal1 oscillations in the periphery is consistent with the potential function of 
miR-494 in the post-transcriptional regulation of Bmal1. In most peripheral tissues, 
Bmal1 accumulation follows a circadian profile in which mRNA levels are high from the 
middle of the night to early morning, and remain low throughout the rest of the cycle 
(Storch et al., 2002; Yamamoto et al., 2004). Hepatic BMAL1 protein content oscillates 
in a similar fashion such that the rhythmic peak occurs late in the subjective night and 
levels rapidly decline near the middle of the subjective day (Lee et al., 2001). Thus, the 
observed oscillations in circulating levels of miR-494 and miR-152 exhibit an interesting 
relationship with reported circadian profiles for Bmal1 in the periphery, with bimodal 
peaks of miRNA expression encompassing times around the rising and falling phases of 
the Bmal1 mRNA as well as protein rhythm . In conjunction with our evidence for miR-
494-mediated repression of the Bmal1 3’ UTR, the bimodal pattern of these serum 
oscillations may have some significance for the function of miR-494 and other miRNAs 
regulating core clock components as local and/or systemic cues that fine-tune the 
circadian harmonics of intercellular interactions and coordinate rhythmicity between 
autonomous circadian oscillators in peripheral tissues.  
 Although both miR-494 and miR-142-3p target the same gene, Bmal1, overt 
rhythmicity in extracellular levels may not be the sole criterion determining their role in 
the mammalian circadian system. Given the abundance of RNases in serum and evidence 
for the rapid degradation of naked synthetic miRNAs in plasma (Reddi and Holland, 
1976; Mitchell et al., 2008), it seems likely that the endogenous serum miRNAs 
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 observed in our experiments are packaged within various types of protective, membrane-
bound particles, such as microvesicles and exosomes. Vesicles released into the 
circulation in vivo presumably arise from a wide variety of cells derived from different 
lineages and subtypes at different stages of maturation, and are distinguished by diverse 
functions. Recent studies indicate that these secreted vesicles mediate the intercellular 
communication of specific RNA signals (Valadi et al., 2007; Yuan et al., 2009; Pegtel et 
al., 2010; Kosaka et al., 2010) and that vesicle-transmitted miRNAs are functional in 
recipient cells (Yuan et al., 2009; Pegtel et al., 2010). Furthermore, different miRNAs 
are packaged in vesicles and exosomes expressing integral cell membrane proteins 
derived from their parental cells of origin, and these cell surface markers appear to 
specify the capture of these particles by certain tissues or cell types. For example, mature 
dendritic cell derived exosomes that express intercellular adhesion molecule-1 (ICAM1) 
are captured largely by lymphocyte function-associated antigen-1 (LFA-1) expressing 
activated T-cells and CD8+ dendritic cells, but not by CD8- dendritic cells (Segura et al., 
2007; Nolte-‘t Hoen et al., 2009). Hence, the distinctive functions of different circulating 
miRNAs in regulating the molecular clockworks or overt circadian rhythms within or 
between specific tissues may be determined not only by temporal variation in 
extracellular levels but also by the parental cells from which the miRNA-containing 
vesicles originate, and by cell-surface receptors on specific target cells that capture these 
circulating vesicles.  
Because a number of processes are subject to circadian regulation in the 
cardiovascular system, circulating miRNAs may play an important role in the local 
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 and/or systemic coordination of circadian rhythms associated with cardiovascular 
physiology and pathology. The cardiovascular system is distinctly characterized by 
circadian regulation of various parameters such as arterial pressure, heart rate, and 
vascular tone (Guo et al., 2003; Shaw et al., 2009). Furthermore, circadian variation is an 
important factor in the manifestation of cardiovascular pathology, including myocardial 
infarction, sudden cardiac death and stroke (Shaw et al., 2009). The role of identified 
miRNAs with Bmal1 as a putative target and rhythmic variations in their circulating 
levels in cardiovascular physiology and disease is currently unknown. However, miR-
494 has been recently implicated in cardiac pathophysiological processes because 
cardiac-specific overexpression of this miRNA reduces myocardial infarction size in 
response to ischemia/reperfusion-induced cardiac injury (Wang et al., 2010c). In 
addition, the recent finding that deletion of several secretory vesicle proteins disrupts 
circadian rhythms of blood pressure and heart rate in the mouse (Kim et al., 2009) may 
have further implications for the role of extracellular miRNAs in regulating 
cardiovascular physiology. Nevertheless, our results suggest that extracellular miRNAs 
may play a role in the regulation of peripheral circadian clocks and that circadian 
profiling and comparison of different serum miRNAs in various disease models may 
provide a valuable tool in identifying biomarkers for human cardiovascular pathologies 
associated with circadian rhythm disturbances. 
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 CHAPTER IV 
MICRORNAS AS CIS- AND TRANS- ACTING MODULATORS OF 
CIRCADIAN RHYTHMS IN PERIPHERAL TISSUES 
 
Introduction 
An endogenous cell-autonomous circadian timekeeping mechanism generates 
rhythmic changes in many physiological and behavioral aspects including body 
temperature, sleep and wakefulness, food intake and locomotor activity. In mammals, 
endogenous clocks are thought to have a hierarchical organization, with the oscillator(s) 
in the suprachiasmatic nuclei (SCN) of the hypothalamus acting as the master pacemaker 
responsible for temporal synchronization of slave oscillators in other tissues and organ 
systems (Ralph et al., 1990; Reppert and Weaver, 2002). The SCN has been shown to 
accomplish this by secretion of diffusible factors and modulation of autonomic nervous 
inputs to peripheral organs (Silver et al., 1996; Allen et al., 2001; Buijs et al., 2003).  
The genes which comprise the core molecular gears of the clock, clock, bmal1, 
period(s) and cryptochrome(s), interact forming a feedback loop that maintains self-
sustained oscillations in core-clock and clock-controlled genes not just in the SCN cells 
but also in most other cells of the body (Shearman et al., 1997; Balsalobre et al., 1998; 
Gekakis et al., 1998; Kume et al., 1999; Bunger et al., 2000; Yoo et al., 2004). As a 
result, even in the absence of SCN specific signals, robust overt rhythmicity in 
peripheral cells and organs has been reported in vitro and under certain conditions in 
vivo. Dispersed mammalian fibroblast cultures were shown to be synchronized by a 
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 serum shock and explants of peripheral organs exhibit robust PERIOD2::LUCIFERASE 
reported circadian bioluminescence rhythms for several days in vitro (Balsalobre et al., 
1998; Yoo et al., 2004). Additionally, SCN-independent circadian rhythms in 
physiology, metabolism and behavior have been reported under restricted feeding and in 
response to chronic drug treatment (Escobar et al., 1998; Tataroglu et al., 2006). 
Although hormones and metabolites have been implicated as potential candidates 
responsible for synchronization of peripheral clocks, it is yet unclear whether local 
paracrine mechanisms for temporal synchronization exist (Dibner et al., 2010). Given 
their rhythmic expression in the circulation, membrane-bound microRNAs (miRNAs) 
might constitute potential signals involved in communication of temporal information 
within local environments in the periphery (Shende et al., 2011).  
MiRNAs are evolutionarily conserved, small non-coding RNAs that are 
generated by sequential processing of larger, primary and premature transcripts 
(Bernstein et al., 2001; Lee et al., 2003; Bartel, 2004). Computational algorithms predict 
that ~20-30% of the mammalian mRNA transcriptome is subject to miRNA-mediated 
regulation and miRNAs have already been shown to play crucial roles in various 
biological processes like development, oncogenesis and immune response (Lewis et al., 
2005; Lindsay, 2008; Sayed and Abdellatif, 2011). Using mouse, fly and chicken model 
systems, miRNAs have also been identified as important modulators of circadian clock 
gene and output rhythms (Cheng et al., 2007; Gatfield et al., 2009; Kadener et al., 2009; 
Shi et al., 2009; Shende et al., 2011; Luo and Sehgal, 2012). MiRNAs primarily function 
as post-transcriptional modulators. They associate with components of the RNA induced 
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 silencing complex (RISC) and interact with specific 3’ untranslated regions (UTRs) of 
their target genes to affect translational repression or mRNA destabilization (Hutvagner 
and Zamore, 2002; He and Hannon, 2004). However, in addition to their presence in the 
cytosol, membrane-bound miRNAs have also been reported extracellularly, in the 
circulation in vivo and in conditioned cell culture medium in vitro (Mitchell et al., 2008; 
Yuan et al., 2009). Importantly, these membrane-bound miRNAs can be communicated 
from donor to recipient cells, where they remain biologically active (Kosaka et al., 2010; 
Kogure et al., 2011).  
Our previous studies indicate that miR-142-3p and miR-494 target the 3’ UTR of 
the core clock gene Bmal1 and are expressed extracellularly in the circulation with miR-
494 exhibiting a diurnal oscillation with bimodal peaks in serum levels (Shende et al., 
2011). To explore the functional implications of these Bmal1-targeting miRNAs in the 
mammalian circadian system, we used serum-shocked fibroblasts to first determine 
whether miR-142-3p and miR-494 modulate endogenous BMAL1 protein levels and 
alter rhythms in core components of the molecular clockworks in a peripheral oscillator 
model. In addition to this analysis of their function in the regulation of clock gene 
rhythmicity, corollary experiments were conducted to address the possible role of miR-
142-3p and miR-494 as extracellular signals that communicate temporal information 
locally among peripheral oscillators.  Specifically, different in vitro models were used to 
determine whether: 1) overexpression of miR-142-3p and miR-494 increases their 
extracellular abundance in culture medium, 2) exposure to conditioned medium from 
miR-142-3p- and miR-494-overexpressing cells increases intracellular expression of 
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 these miRNAs in recipient cells, 3) the internalized miRNAs are functional in recipient 
cells, and 4) disruption of vesicular communication using exocytosis and endocytosis 
inhibitors affects ensemble circadian rhythms.   
 
Materials and Methods 
Cell culture and transfections: NIH/3T3 fibroblasts, immortalized mPer2Luc 
fibroblasts and HEK293 cells were grown in Dulbeco’s minimum essential medium 
(DMEM; Invitrogen) supplemented with 292ug/mL L-glutamine, 4.5ug/mL D-glucose 
and 10% Fetal Bovine Serum (FBS). The medium was replaced every 48h and cultures 
were split 1:3 to 1:5 every 3-4 days. All transfections were performed with 
Lipofectamine 2000 (Invitrogen Inc.) according to the manufacturer’s guidelines.  
Experiment 1- Effects of miR-142-3p and miR-494 overexpression on 
endogenous BMAL1 protein levels and ensemble circadian rhythms of PER2::LUC 
expression: NIH/3T3 and immortalized mPer2Luc fibroblasts were cultured and 
maintained as described above. Prior to experimentation, cells were seeded onto 6-well 
plates in DMEM supplemented with 5% FBS. Approximately 24h later, cells were 
transfected with either a non-targeting control-miR construct or with a combination of 
pre-miR constructs for miR-142-3p and miR-494 (final total conc. = 66nM). Following 
transfection for 5h, control and pre-miR-treated cultures (n=4) were placed in DMEM 
supplemented with 5% FBS. Forty-eight hours post-transfection, cells were collected by 
trypsinization, centrifuged, and pellets were flash frozen in liquid nitrogen. All samples 
were stored at -800C until further processing. 
87 
 
 Analysis of BMAL1 protein levels: The pellets were sonicated in mammalian 
protein extraction reagent (MPER; Pierce, Inc.) supplemented with protease inhibitor 
cocktail (PMSF), and protein content in cell homogenates was measured using the 
bicinchoninic acid method (BCA Protein Assay Kit; Thermo Scientific Pierce). Each 
sample was loaded at ~50μg protein lysate per lane onto a 10% Tris-Glycine gel and 
electrophoresis was performed using an X-blot Mini-cell II apparatus (Invitrogen, Inc.). 
Following separation at 125V for 2h, proteins were transferred onto 0.45μm 
nitrocellulose membranes (Invitrogen) and blocked at room temperature for 1 hour with 
5% skimmed milk in Tris-buffered saline (TBS) supplemented with 0.1% Tween-20 
(TBS-T). With interceding rinses in TBS-T, membranes were probed overnight at 4oC 
with rabbit anti-BMAL1 (1:250; Abcam, Inc.) or a mouse monoclonal antibody against 
β-actin (1:2000; Sigma Inc.) followed by a 1-h incubation with horse-radish peroxidase 
(HRP)-conjugated donkey anti-rabbit IgG (1:1000; Jackson Laboratories) or goat anti-
mouse IgG (1:2000; Jackson Laboratories). Immunoreactive signal for BMAL1 was 
generated using enhanced chemiluminescence (ECL) reagent (Thermo Scientific Pierce) 
and luminescence for size-appropriate bands were detected using a FluorChem Gel 
imaging system (Alpha Innotech Corp.). To control for differences in protein content 
between samples, signal intensity measurements for BMAL1 were normalized to the 
values for β-actin in each sample. Densitometric analyses for immunoreactive bands 
were performed using NIH ImageJ software.  
Analysis of PER2::LUC rhythms: To examine the function of miRNAs targeting 
Bmal1 in the regulation of circadian rhythms, bioluminescence was analyzed from 
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 mPer2Luc fibroblast cultures that were transfected with pre-miR constructs for miR-142-
3p and miR-494 as described above. About 24h hours post-transfection, cultures were 
serum shocked for 2h with DMEM supplemented with 50% horse serum After serum 
shock treatment, cultures were maintained in DMEM recording media (Sigma-Aldrich) 
containing 10mM HEPES, 0.03% NaHCO3, N2 supplement (1X; Invitrogen), 4.510g/L 
glucose, 25 units/ml penicillin, 25μg/ml streptomycin and 0.1mM beetle luciferin 
(Promega, Madison, WI), and analysis of mPer2Luc bioluminescence was initiated. 
Real-time analysis of PER2::LUC bioluminescence: Individual cultures were 
sealed airtight with sterile glass coverslips (VWR) and sterile silicon grease (Dow 
Corning, Inc.). The temporal patterns of mPER2::LUC bioluminescence were analyzed 
using an automated 32-channel luminometer (LumiCycle; Actimetrics, Wilmette, IL) 
that was maintained within a standard cell culture incubator at 320C. Bioluminescence 
from individual cultures was continuously recorded with a photomultiplier tube for ~70 s 
at intervals of 10 min for 4–5 days. Due to the transient induction of bioluminescence 
following the medium change at the initiation of this analysis, the first cycle was 
excluded from data analysis. Bioluminescence data were analyzed using the Lumicycle 
Analysis program (Actimetrics). For each raw data set, baseline drift was removed by 
fitting a polynomial curve with an order equal to the number of recorded cycles. Rhythm 
parameters (period, phase and damping) were determined from baseline-subtracted data 
using the damped sine fit and the Levenberg–Marquardt algorithm. 
Experiment 2- Export and internalization of miR-142-3p and miR-494 in 
NIH/3T3 and HEK293 cultures: Timekeeping functions and communication of 
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 extracellular miRNAs was investigated using HEK293 and NIH/3T3 cell culture models 
of peripheral circadian oscillators. 
Export of miR-142-3p and miR-494 into culture medium: Studies examining 
intercellular communication of miRNAs were performed using NIH/3T3 and HEK293 
cells as depicted (Fig. 15). On day 0, donor NIH/3T3 or HEK293 cultures were seeded 
onto 24-well plates in DMEM supplemented with 5% FBS. Approximately 24h later 
(day 1), cells were transfected either with CmiR001-MR04 control vector encoding a 
scrambled precursor miRNA (Genecopoeia) or with a combination of miExpress™ 
precursor miRNA expression clones for mmu-miR-142 and mmu-miR-494 (n=4; final 
conc. = 0.8ug of plasmid/well). These expression clones contain the premature miRNA 
sequence inserted in the pEZX-MR04 vector downstream of an eGFP fluorescent 
reporter gene under the control of a CMV promoter. Following transfection for 4-5h, 
cells were rinsed with CMF and then maintained in DMEM supplemented with 5% FBS. 
Aliquots of the conditioned culture medium were collected at 12h, 24h (day 2) and 36h 
(day 3) post-transfection, and then flash frozen in liquid nitrogen. All conditioned media 
samples were stored at -800C until further processing. 
Uptake of miR-142-3p and miR-494 from conditioned medium: For miRNA 
uptake experiments, recipient cultures were seeded onto 24-well plates on day 2 of the 
experiment. On day 3, the recipient cells were rinsed with CMF and exposed to 
conditioned medium collected at 36h post-transfection from CmmiR001-MR04- 
(scrambled control) or pEZX-MR04 (miR-142 + miR-494)-transfected donor cells. 
Recipient cells were then collected by trypsinization following 2h, 4h and 8h of 
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 exposure to this scrambled control- or miR142+miR-494-containing conditioned 
medium (n=4 at each timepoint). Trypsinized cells were pelleted by centrifugation, the 
cell pellets were flash frozen in liquid nitrogen and stored at -800C until further 
processing. 
RNA extraction from cells and conditioned culture medium: Total RNA, 
including the small RNA fraction was extracted using miRNeasy kit (Qiagen) from: 1) 
donor cells collected at 36h post-transfection, 2) donor cell culture conditioned medium 
collected at 12h, 24hand 36h post-transfection, and 3) recipient cells collected at 2h, 4h 
and 8h of exposure to donor cell conditioned medium. Extracted RNA was estimated 
using Nanodrop ND1000 spectrophotometer (Thermo Scientific), aliquoted and stored at 
-800C until further processing. 
Quantative Real-time PCR analysis: Quantitative real-time PCR analysis was 
conducted using Taqman microRNA assays (Applied Biosystems) as described 
previously (Shende et al., 2011). Briefly, RNA from individual samples was first reverse 
transcribed using target-specific stem-loop primers and Taqman MicroRNA Reverse 
Transcription Kit. All assays were performed according to manufacturer's guidelines. 
For analysis of miRNA expression, the cDNA equivalent of 2ng of total RNA was PCR 
amplified in an ABI PRISM 7500 Fast sequence detection system.  To control for 
differences in sample RNA content and reverse-transcription efficiencies between 
samples, miR-16 was also amplified from the same samples using identical parameters. 
Using the comparative CT method described in the ABI Prism 7700 Sequence Detection 
System User Bulletin #2 (PE-ABI), the relative abundance for a given miRNA was 
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 calculated by normalization first to corresponding miR-16 levels in each sample and 
then to a calibrator consisting of pooled cDNA from multiple samples comprising the 
experimental series. 
Experiment 3- Effects of disrupting vesicular communication on ensemble 
circadian rhythms of PER2::LUC expression: Effects of exocytosis and endocytosis 
inhibitors on PER2::LUC rhythms were examined using mPer2Luc fibroblasts that were 
seeded onto 35mm cell culture dishes (Corning) in DMEM supplemented with 5% FBS. 
At confluence (~24 hours later), cultures were serum shocked  for 2h  with DMEM 
supplemented with 50% adult horse serum. Following the serum shock treatment, 
PER2::LUC bioluminescence rhythms were monitored for 68-72h in cells (n=4 for 
control and each treatment) that were maintained in serum-free recording medium 
containing either vehicle control (DMSO; 5uL/mL), exocytosis inhibitor (Brefeldin-A; 
conc. 0.15ug/mL), or endocytosis inhibitor (Dynasore; conc. 40uM). Following 
treatment, both DMSO- and inhibitor drug-treated cells were rinsed with CMF, serum 
shocked again for 2h, and PER2::LUC bioluminescence rhythms were monitored for 
another 72h. Bioluminescence data were analyzed as described above. 
Statistical analyses: Values obtained for densitometric analyses of normalized 
BMAL1 protein expression levels and for intracellular and conditioned medium miRNA 
expression comparisons were analyzed by independent t-tests. The α-value was set at 
0.05 to identify statistically significant differences between treatment and controls. 
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 Results 
Experiment 1- Effects of miR-142-3p and miR-494 overexpression on 
endogenous BMAL1 protein levels and ensemble circadian rhythms of PER2::LUC 
expression: Based on the identification of miR-142-3p and miR-494 as potential 
repressors of Bmal1 3’ UTR activity in the previous study, we examined the function of 
these miRNAs in repressing endogenous BMAL1 protein levels. Combinatorial 
overexpression of miR-142-3p and miR-494 resulted in significant repression (p<0.05) 
of BMAL1 protein levels compared to cells transfected with a non-targeting control (Fig. 
13A). In cells transfected with miR-142-3p and miR-494, this repression in BMAL1 
protein levels ranged from 18-56% of control values. Because BMAL1 is an integral 
component of the molecular clock mechanism (Bunger et al., 2000), experiments were 
conducted to determine whether overexpression of these BMAL1-targeting miRNAs 
also affects ensemble circadian rhythms in culture. Real-time recording of PER2::LUC 
bioluminescence from mPer2Luc fibroblasts revealed severe disruption of ensemble 
rhythms in miR-142-3p+miR-494-transfected cultures (Fig. 13B). Compared to control-
transfected cells, the period of the PER2::LUC rhythms in miRNA overexpressing 
cultures was significantly increased (p<0.001) by ~7h. Overexpression of miR-142-3p 
and miR-494 also induced a ~50% reduction in rhythm amplitude and a significant 
increase (p<0.001) in rhythm damping rate relative to control cultures (Fig. 13B & Table 
2). Collectively, these results suggest that tonic increases in intracellular levels of miR-
142-3p and miR-494 may alter ensemble rhythmicity via their action on Bmal1. 
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Figure 13. Effects of overexpression of miR-142-3p and miR-494 on BMAL1 protein 
expression and ensemble PER2::LUC bioluminescence rhythms. (A) Representative 
Western blot results and densitometric analysis of BMAL1 protein levels in scrambled 
control (black bars) and pre-miR-142-3p+pre-miR-494 (red bars) transfected NIH/3T3 
cells (n=4). Plotted values represent the relative optical density (mean ± SEM) and 
correspond to the ratios of BMAL1/β-ACTIN immunoreactive signal that were adjusted 
in relation to the average for the control-transfected cells, which was arbitrarily set at 
100. Asterisks denote values for relative protein levels in pre-miR-transfected cells that 
were significantly decreased (p<0.05) in comparison with those observed in controls. (B) 
Photomultiplier-based recordings of ensemble bioluminescence (expressed as detrended 
baseline-subtracted counts per second) from individual cultures of mPer2Luc fibroblast 
cells transfected with scrambled control (black traces) or pre-miR-142-3p+pre-miR-494 
(red traces) constructs (n=3). 
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 Table 2. Cycle parameters for PER2::LUC bioluminescence rhythms following miRNA 
overexpression. 
  Period (mean + SEM) Damping (mean + SEM) 
Control 24.77 (+ 0.22) 1.02 (+ 0.02) 
miR-142-3p+miR-494 31.84 (+ 0.59)* 0.78 (+ 0.01)* 
 
 
Experiment 2- Export and internalization of miR-142-3p and miR-494 in 
NIH/3T3 and HEK293 cultures: To accurately determine changes in intracellular and 
extracellular miRNAs after transfection with pEZX-MR04 miRNA expression vectors, 
we first analyzed the endogenous baseline expression of miR-142-3p and miR-494 in 
HEK293 and NIH/3T3 cells (Fig. 14A). In both, NIH/3T3 and HEK293 cells, the 
relative expression of endogenous miR-494 was significantly, ~300-fold and ~65-fold 
respectively, higher than endogenous expression of miR-142-3p (p<0.001). 
Consequently, transfection with pEZX-MR04-miR-142 miRNA expression vector 
resulted in ~180-fold and ~1800-fold upregulation of intracellular miR-142-3p levels in 
miRNA expression vector transfected NIH/3T3 and HEK293 cells respectively 
compared to control transfectants (p<0.001; Fig. 14B & 14C). However, given its higher 
intracellular abundance, miR-494 was significantly and ~7-fold higher only in pEZX-
MR04-miR-494 miRNA expression vector transfected HEK293 cells (p<0.01) (Fig. 
14B). The intracellular levels of miR-494 in NIH/3T3 cells did not exhibit significant 
changes even after transfection with the miR-494 miRNA expression vector (Fig. 14C). 
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Figure 14. Comparison of intracellular levels of miR-142-3p and miR-494 in HEK293 
and NIH/3T3 cells. (A) Bars represent real-time PCR determinations (mean + SEM) of 
endogenous miR-142-3p (black bars) and miR-494 (red bars) in HEK293 (left panel) 
and NIH/3T3 (right panel) cultures (n=4). The plotted values correspond to the ratios of 
intracellular miR-142-3p and miR-494 signal in non-transfected HEK293 and NIH/3T3 
cells. Asterisks denote comparisons in which the relative expression of miR-142-3p 
signal was significantly different (p<0.05) from that of miR-494. (B & C) Bars represent 
real-time PCR determinations (mean + SEM) of miR-142-3p (left panels) and miR-494 
(right panels) in HEK293 (B) and NIH/3T3 (C) cultures. Plotted values correspond to 
the ratios of intracellular miRNA signal, in cultures (n=4) transfected with pEZX-MR04-
control vector (black bars) or with a combination of pEZX-MR04-miR-142 + pEZX-
MR04-miR-494 vectors (red bars), and were adjusted in comparison with the average for 
miRNA expression in control-transfected cultures that was arbitrarily set as 1.  
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 To assess whether miR-142-3p and miR-494 are expressed extracellularly in vitro in 
conditioned cell culture medium, HEK293 and NIH/3T3 cells were co-transfected with a 
combination of pEZX-MR04-miR-142 and pEZX-MR04-miR-494 expression vectors. 
Conditioned culture medium was collected at timed intervals post-transfection and 
expression of miR-142-3p and miR-494 relative to miR-16 was estimated as depicted in 
Fig. 15. At each timepoint, expression of miR-142-3p and miR-494 were significantly 
higher (p<0.01) in conditioned medium from HEK293 cells transfected with the miRNA 
expression vectors compared to conditioned medium from cells transfected with a vector 
encoding a non-targeting scrambled control miRNA (Fig. 16A). The extracellular 
expression of miR-142-3p in conditioned medium from miRNA-transfected cells 
increased steadily such that levels of miR-142-3p at 24h and 36h were significantly 
higher (p<0.01) than those at 12hr. Peak miR-142-3p expression was achieved at 36h 
and was ~60-fold higher in conditioned medium from miRNA expression vector-  
compared to scrambled control- transfected cells. Similar to miR-142-3p, extracellular 
expression of miR-494 at each timepoint was also significantly greater (p<0.01) in 
conditioned medium from miRNA-transfected cells compared to that from cells 
transfected with a scrambled control vector (Fig. 16A). Interestingly, the peak in 
extracellular expression of miR-494 was observed at 24h with ~75-fold increase in 
conditioned medium from miRNA-transfected cells compared to controls. At 36hr, the 
miR-494 expression in conditioned medium from miRNA-transfected cells decreased to 
~50% of that observed at 24h (Fig. 16A). Extracellular expression of miR-142-3p and 
miR-494 in conditioned medium from NIH/3T3 cells was similar to that observed with 
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 HEK293 conditioned medium. Specifically, miR-142-3p and miR-494 levels were 
significantly higher (p<0.01) than those found in control-transfected conditioned 
medium with miR-142-3p increasing over time while peak accumulation of miR-494 
occurring earlier, at 12h (Fig. 16B). 
 
 
 
Figure 15. Experimental paradigm for miRNA communication experiments. 
Diagrammatic representation of the paradigm used for experiments testing miRNA 
export into and internalization from conditioned culture medium. 
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Figure 16. Comparison of conditioned medium levels of miR-142-3p and miR-494 in 
HEK293 and NIH/3T3 cells. Bars represent real-time PCR determinations (mean + 
SEM) of miR-142-3p (top panels) and miR-494 (bottom panels) at 12h, 24h and 36h in 
conditioned medium from HEK293 (A) and NIH/3T3 (B) cultures. Plotted values 
correspond to the ratios of miRNA signal in conditioned medium from cultures (n=4) 
transfected with pEZX-MR04-control vector (black bars) or with a combination of 
pEZX-MR04-miR-142 + pEZX-MR04-miR-494 vectors (red bars), and were adjusted in 
comparison with the average for miRNA expression in control-transfected cultures at 
each timepoint that was arbitrarily set as 1. Asterisks denote comparisons in which the 
relative expression of miRNA signal in control-transfected cultures was significantly 
different (p<0.05) from that in miR-142+miR-494-transfected cultures. 
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Figure 17. Comparison of intracellular levels of miR-142-3p and miR-494 in HEK293 
and NIH/3T3 cells exposed to conditioned culture medium. Bars represent real-time 
PCR determinations (mean + SEM) of miR-142-3p (top panels) and miR-494 (bottom 
panels) in HEK293 (A) and NIH/3T3 (B) cultures after 4h and 8h of exposure to 
conditioned medium from control- or miR-142+miR-494-transfectd cultures. Plotted 
values correspond to the ratios of intracellular miRNA signal, in cultures (n=4) exposed 
to conditioned medium from control-transfected (black bars) or from miR-142+miR-
494-transfected (red bars) cultures, and were adjusted in comparison with the average for 
miRNA expression in control-transfected cultures that was arbitrarily set as 1. Asterisks 
denote comparisons in which the relative expression of miRNA signal in cultures 
exposed to control-transfected conditioned medium was significantly different (p<0.05) 
from that in cultures exposed to miR-142+miR-494-transfected conditioned medium.  
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 Whether the extracellular miRNAs in conditioned culture medium were 
biologically active, was analyzed by determining whether the miRNAs could be 
internalized by recipient cells. Exposure to miRNA-containing conditioned medium 
produced significant increases (p<0.001) in miR-142-3p levels in the recipient HEK293 
cells. Compared to control miR-containing conditioned medium, intracellular levels of 
miR-142-3p were elevated by 40- and 35-fold after 4h and 8h of exposure to miRNA 
conditioned medium, respectively (Fig. 17A). Relative to controls, recipient NIH/3T3 
cells also exhibited modest but significant elevation (p<0.05) in intracellular miR-142-3p 
levels at 4h and 8h of exposure to miRNA conditioned medium (Fig. 17B). Given the 
high endogenous expression of miR-494, it is not surprising that we did not observe 
significant elevation in intracellular miR-494 levels in either HEK293 or NIH/3T3 
recipient cells after exposure to miRNA-conditioned medium.  
To further validate vesicle mediated communication of miRNA signals between 
donor and recipient cells, recipient cells were treated with Dynasore, an endocytosis 
inhibitor for the duration of their exposure to conditioned medium from control or 
miRNA transfected donor cells. Inhibition of endocytosis significantly abated increases 
in intracellular miR-142-3p even after exposure to miRNA-conditioned medium (Fig. 
18A). There was no significant difference in intracellular miR-142-3p levels between 
recipient cells exposed for 8h either to control- or to miRNA- conditioned medium. For 
further verification, the experimental paradigm was modified such that immediately 
following transfection with either control or miRNA expression vector, donor cells were 
treated with Brefeldin-A (BFA), an exocytosis inhibitor and conditioned medium was 
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 collected as described above. Exposure of recipient cells to BFA-treated control- or 
miRNA- conditioned medium for 8h did not result in significant differences in 
intracellular miR-142-3p levels between recipient cells exposed either to control or to 
miRNA-conditioned medium (Fig. 18A). Thus both, inhibition of exocytosis in donor 
cells, and inhibition of endocytosis in recipient cells had similar effects in inhibiting 
communication of extracellular miRNAs between donor and recipient cells (Fig. 18A). 
We next investigated whether the communicated miR-142-3p retained its biological 
activity in recipient cells by examining the effects of exposure to miRNA-containing 
conditioned medium on the Bmal1 3’ UTR activity in recipient HEK293 cells (Fig. 
18B). Exposure to miRNA-containing conditioned medium for 8h significantly reduced 
(p<0.05) luciferase-reported bioluminescence in Bmal1 3′ UTR-expressing cells relative 
to that in control vector transfectants, implicating that the elevated intracellular miR-
142-3p was functional in the recipient cells. 
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Figure 18. Effects of exocytosis and endocytosis inhibitors on miR-142-3p uptake and 
functional activity of miR-142-3p in recipient cells. (A) Bars represent real-time PCR 
determinations (mean + SEM) of miR-142-3p in HEK293 cultures after 8h of exposure 
to conditioned medium from control-transfected (black bars) or miR-142+miR-494-
transfectd (red bars) cultures. Plotted values correspond to the ratios of intracellular 
miRNA signal, in cultures (n=4) and was adjusted in comparison with the average for 
miRNA expression in control-transfected cultures that was arbitrarily set as 1. (B) Bars 
denote normalized bioluminescence (mean ± SEM) determinations from HEK293 cells 
expressing the control or Bmal1 3′ UTR vector in response to treatment with miRNA 
conditioned culture medium for 8h (n = 4). The plotted values correspond to the ratios of 
firefly luciferase signal normalized to Renilla luciferase activity in the same sample and 
are represented as a percentage of the average signal for control vector transfectants 
which was arbitrarily set at 100. Asterisks indicates normalized bioluminescence signal 
in cultures expressing control-vector was significantly different (p<0.05) from that in 
cultures expressing Bmal1 3’ UTR vector.  
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 Experiment 3- Effects of disrupting vesicular communication on ensemble 
circadian rhythms of PER2::LUC expression: To assess the potential role of vesicle-
mediated communication in the regulation of temporal synchrony among peripheral 
circadian oscillators, the effects of exocytosis or endocytosis inhibitors on ensemble 
rhythmicity of mPer2Luc fibroblasts were analyzed. During treatment with Brefeldin-A 
(BFA), the period of PER2::LUC bioluminescence rhythm was significantly lengthened 
(p<0.001). In addition to increasing the period by~7h, BFA induced severe damping of 
rhythm amplitude such that there was no observable peak in PER2::LUC 
bioluminescence by the third day of treatment (Fig. 19A and Table 3). Similar to the 
effects of exocytosis inhibitor, treatment with the endocytosis inhibitor, Dynasore, 
significantly increased (p<0.001) the period of the PER2::LUC rhythm. In Dynasore-
treated mPer2Luc fibroblasts, circadian period was increased by ~9h relative to that 
observed in vehicle controls (Fig. 19B and Table 3). However, Dynasore treatment had 
no effect on the amplitude of the PER2::LUC rhythm. Both drugs are reversible 
inhibitors, and post-treatment rhythms resembled those observed in vehicle control 
cultures. Some residual effects of BFA on rhythm amplitude were transiently observed 
during the 1st day after drug treatment. However, other rhythm parameters such as period 
and damping rate were comparable during subsequent cycles (p>0.05). In Dynasore-
treated cultures, post- treatment rhythm amplitude and damping were similar to those 
observed in control cultures. However, the increase in circadian period persisted after 
drug washout. 
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Figure 19. Effects of exocytosis or endocytosis inhibitors on ensemble PER2::LUC 
bioluminescence rhythms. (A & B) Representative individual photomultiplier-based 
recordings of ensemble bioluminescence (expressed as detrended baseline-subtracted 
counts per second) from representative cultures of mPer2Luc fibroblast cultures (n=4) 
treated with DMSO vehicle control (black traces), Brefeldin-A (red traces, A) or 
Dynasore (red traces, B).  Grey shaded region represents drug- or vehicle control- 
treatment, pink shaded region represents post-treatment serum-shock and non-shaded 
region represents post-treatment recovery.  
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 Table 3. Cycle parameters for PER2::LUC bioluminescence rhythms following 
treatment with Brefeldin-A or Dynasore. 
 During Treatment (mean + 
SEM) 
Post-treatment (mean + SEM) 
 Period Damping Period Damping 
DMSO 21.21 (+ 0.56) 0.96 (+ 0.04) 23.65 (+ 0.18) 1.25 (+ 0.04) 
BFA-0.15ug 30.36 (+ 0.85)* 0.95 (+ 0.03) 24.94 (+ 1.28) 1.51 (+ 0.15) 
         
 
DMSO 
 
21.10 (+ 0.17) 1.39 (+ 0.11) 26.93 (+ 0.17) 2.14 (+ 0.03) 
DYNA-30uM 30.06 (+ 0.28)* n/a 29.13 (+ 0.43)* 2.03 (+ 0.19) 
 
 
Discussion 
 Numerous studies have independently demonstrated extracellular expression of 
miRNAs, both in the circulation in vivo and in conditioned medium from cultured cells 
in vitro (Valadi et al., 2007; Gilad et al., 2008; Hunter et al., 2008; Mitchell et al., 2008; 
Yuan et al., 2009; Wang et al., 2010b). Because distinctive miRNAs signatures 
characterize various diseases, much attention has been focused on the use of circulating 
miRNAs as diagnostic or prognostic biomarkers of pathologies (Chen et al., 2008; 
Rabinowits et al., 2009; Huang et al., 2010; Wang et al., 2010a). Whether these 
extracellular miRNAs are by-products of cellular activity and only have diagnostic 
potential or if they are active moieties with functional and therapeutic importance remain 
fundamental questions yet to be clearly answered. In this regard, our study examines 
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 whether extracellular miRNAs can potentially communicate temporal information 
between cells. Specifically, the findings indicate that miR-142-3p and miR-494, which 
are expressed in the circulation in mouse serum, can function intracellularly to repress 
endogenous BMAL1 protein and modulate ensemble circadian rhythms of cultured cells. 
Additionally, miR-142-3p and miR-494 can be secreted into extracellular environments 
and may be communicated between cells in vitro by vesicular trafficking. 
The circadian system is composed of cell-autonomous clocks present in most 
cells of the body. Efficient functioning and fine-tuning of rhythmic physiological and 
behavioral outputs depends on two factors; first, the precise functioning of each 
intracellular core oscillator, and second, effective communication of temporal 
information among clocks both locally, within in a tissue or organ system, and globally, 
between various central and peripheral organ systems. Using NIH/3T3 fibroblasts, we 
provide primary evidence that combinatorial overexpression of miR-142-3p and miR-
494 can repress endogenous BMAL1 protein expression by ~33% compared to cells 
overexpressing a scrambled control miRNA. The protein repression potentially also 
affects ensemble circadian rhythms of cells in culture since miR-142-3p and miR-494 
overexpressing fibroblasts exhibit lengthened period and faster damping of PER2::LUC 
reported bioluminescence rhythms. Thus, our data implicate miR-142-3p and miR-494 
as important post-transcriptional modulators of the intracellular core circadian 
timekeeping machinery.  
Although the master pacemaker in the SCN is thought to effect synchronized 
behavioral output rhythms by secretion of diffusible factors like prokineticin 2, TGF-α 
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 and cardiotropin-like cytokine (Kramer et al., 2001; Cheng et al., 2002; Kraves et al., 
2006), it is unclear if local temporal communication also occurs between or within 
peripheral clocks. By utilizing pEZX-MR04 miRNA expression vectors, and two cell 
lines as model systems for peripheral clocks, we analyzed in vitro, whether miRNAs 
could be expressed extracellularly and could be communicated between cells. It is 
important to note that in contrast to chemically stabilized miRNA mimics like Pre-miR 
miRNA overexpression constructs, the pEZX-MR04 miRNA expression vector used 
during these studies codes for stem-loop premature miRNAs that undergo processing by 
Dicer to yield the mature miRNA. The miRNAs thus generated utilize part of the 
endogenous miRNA biogenesis machinery and hence potentially faithfully reproduce 
biogenesis, processing, accessibility and stability characteristics identical to those of 
corresponding endogenous miRNAs. Compared to conditioned medium from scrambled 
control miRNA transfected cultures, we detected robust, sustained increases with time in 
extracellular miR-142-3p expression in conditioned medium collected from both, 
HEK293 and NIH/3T3 cells transfected with pEZX-MR04-miR-142 miRNA expression 
vector. It was recently reported in studies involving multiple cell types including 
HEK293, MCF7, mouse mast and dendritic cells that miR-142-3p is preferentially 
exported into extracellular environments (Guduric-Fuchs et al., 2012). Thus, it is 
possible that the sustained increase in extracellular miR-142-3p could either be a result 
of its continuous intracellular transcription from the pEZX-MR04 vector, or its 
preferential export out of the cells, or a combination of both. Extracellular expression of 
miR-494 was also significantly higher (by ~60-70 fold) in conditioned medium from 
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 HEK293 and NIH/3T3 cells transfected with miRNA expression vector compared to 
corresponding levels in conditioned medium from control miRNA transfected cultures. 
This was surprising, given that transfection with the pEZX-MR04-miR-494 miRNA 
expression vector had resulted only in modest increases (~6-fold) in intracellular miR-
494 in HEK293 cells, and no difference in intracellular miR-494 levels in NIH/3T3 cells. 
Our data thus raise the intriguing possibility that specific homeostatic mechanisms 
regulating intracellular levels of miR-494 might exist, and perturbations of these levels 
as achieved by transfection with miR-494 expression vector may result in preferential 
export of excess miRNA molecules out of the cell. Additionally, in both cell types 
tested, extracellular miR-494 levels exhibited differences between 12h, 24 and 36h after 
transfection with the miRNA expression vector. In HEK293 cell culture conditioned 
medium, miR-494 levels at 24h were significantly and ~2-fold higher than those 
observed at 36h. miR-494 expression in NIH/3T3 conditioned medium at 12h was 
similarly ~2-fold higher than corresponding levels at 36h. Our previous in vivo data have 
identified diurnal oscillations in miR-494 expression characterized by 3-4 fold 
differences in serum levels of this miRNA over an 8-12h period. Although the cause of 
this reduction over time is unclear, the change in extracellular miR-494 levels observed 
in vitro may be a result of miRNA re-uptake or of lower stability of extracellular miR-
494, or a combination of both. 
The observation that exposure to miRNA containing conditioned medium 
resulted in increased levels and corresponding functional activity of intracellular miR-
142-3p in recipient cells suggests that miR-142-3p, and potentially other extracellular 
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 miRNAs, might be communicated between cells. Because extracellular vesicles like 
exosomes and microvesicles have been shown to transport miRNA cargo between cells 
(Kosaka et al., 2010; Kogure et al., 2011), we used exocytosis and endocytosis inhibitors 
to assess the effects of disruption of vesicular communication on miRNA transfer 
between cells and on ensemble circadian rhythms in culture. Treatment with either 
inhibitor resulted in significant lengthening of the period of PER2::LUC reported 
bioluminescence rhythms in fibroblasts. Dynasore disrupts endocytosis by inhibition of 
dynamin, which is required for calthrin-coating of endocytic vesicles. Using shibire, 
which is a loss of function mutation in dynamin, other studies have reported similar 
increases in the period of circadian free-running behavioral rhythms in Drosophila 
(Kilman et al., 2009; Wulbeck et al., 2009). Dynasore treatment was also reported to 
cause decreased amplitude of rhythms in mouse SCN slice cultures (Deery et al., 2009). 
Thus, effects of endocytosis inhibition on ensemble circadian rhythms in culture and in 
vivo have also been verified by two other independent reports. Although aberrant 
neurotransmitter release due to disrupted vesicular communication might explain some 
of the effects observed in SCN cultures or in Drosophila mutants, the PER2::LUC 
fibroblast cell line used in this study is devoid of neurons. Thus, our data suggest that 
miRNAs, either independently or synergistically with other protein or small molecule 
components of extracellular vesicles, might facilitate temporal synchronization between 
cells within local environments in the periphery. 
For miRNAs to function as signaling molecules, specificity of communication of 
candidate miRNAs would be an important consideration. The specificity can potentially 
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 be generated at multiple levels: 1) biogenesis within the donor cell or tissue type, 2) 
vesicular packaging of miRNAs and export out of cells, and 3) uptake by recipient cells. 
Some evidence supporting regulation at these different levels already exists. For 
example, recent studies have described cell-type dependent preferential export of 
miRNAs such that expression of some miRNAs may be higher in extracellular vesicles 
than in parental cells (Mittelbrunn et al., 2011; Pigati et al., 2010; Wang et al., 2010b; 
Guduric-Fuchs et al., 2012). Additionally, there is growing evidence concerning 
selective packaging of certain miRNAs into vesicles (Zhang et al., 2010; Hergenreider et 
al., 2012). Although the mechanistic details are yet unclear, cell- or tissue-type 
dependent vesicle export mechanisms could also account for specificity of miRNA 
signaling. Extracellular vesicles contain cell-surface markers characteristic of their donor 
cell types. These cell surface markers can mediate preferential uptake of vesicles by 
specific donor cells as seen in mature dendritic cell derived exosomes expressing 
intercellular adhesion molecule-1 (ICAM1) being preferentially captured by lymphocyte 
function-associated antigen-1 (LFA-1) expressing activated T-cells and CD8+ dendritic 
cells, but not by CD8− dendritic cells (Segura et al., 2007; Nolte-‘t et al., 2009). 
Although the specific contribution(s) of each level of regulation to communication of 
temporal information by extracellular miRNAs is yet unclear, our results provide 
evidence that extracellular miRNAs may play a role in temporal synchronization of 
peripheral clocks with local environments in the periphery. 
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 CHAPTER V 
GENERAL DISCUSSION AND CONCLUSIONS  
 
The circadian timekeeping system is composed of a network of cell-autonomous 
oscillators that receive environmental information via input pathways, interact among 
each other via physical connections or diffusible factors and generate rhythmic outputs 
that function as an ensemble to help an organism anticipate temporally influenced events 
throughout the day. In mammals, the SCN is considered the seat of the master 
pacemaker responsible for synchronizing rhythms in central and peripheral oscillators. 
For accurate functioning, this complex system is regulated at three levels: 1) the 
intracellular molecular timekeeping machinery in each cell that contains a clock, 2) 
synchronization of cell-autonomous clocks within local environments in the SCN and in 
peripheral tissue(s), and 3) synchronization of clocks globally, that is, between SCN and 
peripheral tissues or among two or more peripheral tissues. This dissertation focuses on 
two of these fundamental levels, aiming to deduce the role of miRNAs in regulation of 
the intracellular clock machinery and in communication of temporal information to help 
generate synchrony among cell-autonomous clocks within local environments. 
 
miRNAs as Ancillary Loops Stabilizing the Intracellular Clockwork 
For more than a decade, the core transcriptional-translational feedback loop was 
considered to be sufficient and necessary for the generation of circadian rhythms in 
mammals. However, recent studies have encouraged re-evaluation of this view. 
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 Circadian rhythms in redox cycles of the antioxidant proteins, peroxiredoxins, were 
observed in human red blood cells (RBC’s), indicating that non-transcriptional events 
were sufficient in sustaining some cellular circadian rhythms (O’Neill and Reddy, 2011). 
Additionally, comparisons of circadian transcriptome and proteome revealed that less 
than 50% of rhythmic proteins had mRNAs that were also rhythmic, indicating 
significant post-transcriptional or post-translational regulation of circadian genes (Deery 
et al., 2009).  
In this regard, the data presented here suggests that miRNAs perform a 
modulatory role by interacting with core clock gene(s) to effectively fine-tune the 
intracellular clock machinery. The salient observations supporting this position are: 1) 
miR-142-3p is expressed rhythmically in the mouse SCN, in vivo, and in an 
immortalized SCN cell line in vitro, 2) miR-142-3p targets two locations in the 3’ UTR 
of the core clock gene Bmal1, 3) overexpression of miR-142-3p in SCN cells causes 
disruption of BMAL1 protein rhythms, and 4) combinatorial overexpression of miR-
142-3p and miR-494 represses BMAL1 protein levels and causes disruption of ensemble 
circadian rhythms in cultured fibroblasts in vitro.  
During the preparation of this dissertation, another study was published 
implicating miR-142-3p as a target of BMAL1-mediated transcription in NIH/3T3 cells. 
The authors validated an E-box element upstream of the miR-142 locus as the site of 
CLOCK-BMAL1 heterodimer binding. On serum-shock, fibroblasts also exhibited 
rhythmic accumulation of mature miR-142-3p and of Bmal1 mRNA with phase angles 
similar to what we have observed in our SCN samples. The same report also 
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 demonstrated miR-142-3p mediated repression of BMAL1 protein levels in HEK293 
and in NIH/3T3 cells (Tan et al., 2012). Additionally, a previous study profiling diurnal 
oscillations in the miRNA transcriptome of liver had indicated that miR-142-5p was 
rhythmic in the liver with peak expression occurring around ZT8 (Na et al., 2009). Two 
mature miRNAs, miR-142-3p and miR-142-5p, are both synthesized from the common 
premature miRNA, pre-miR-142. Based on the data from Tan et al. (2012), indicating 
that miR-142-3p is rhythmically expressed in serum shocked NIH/3T3 fibroblasts, it is 
likely that miR-142-3p may also be rhythmic in peripheral tissues, like the liver. 
Interestingly, the reported peak for miR-142-5p at ZT8 in the mouse liver is ~5h phase 
delayed compared to our observations that miR-142-3p expression in the SCN peaks 
around CT3. This delay is consistent with other published reports regarding the phases 
of molecular rhythms in SCN compared to peripheral tissues (Panda et al., 2002). 
Although transcriptome analyses have revealed that rhythmic mRNAs in the SCN and 
peripheral tissues only share minor overlap, essential elements of the molecular clock are 
rhythmic in almost all tissues tested so far. Thus, rhythmicity of miR-142-3p expression 
in the SCN and possibly in the liver is consistent with its potential intrinsic involvement 
in modulating core intracellular clock machinery in both SCN and in peripheral clocks. 
How crucial is miRNA-mediated regulation by miR-142-3p or by other miRNAs 
in general? I posit that miRNAs interact either with core clock genes or other factors 
influencing core clock genes and give rise to additional feed-back loop(s) that further 
stabilize the molecular clock (Fig. 20). Support for this assertion comes from theoretical 
models recently proposed by Liu and Wang (2012), who introduced variables including 
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 miRNA expression and degradation rate (for miR-219 and miR-132) into classical 
transcription-translation based models, and compared outputs of the new equations with 
recently published empirical data. Incorporation of miRNAs into classical models did 
not significantly alter oscillations of Bmal1, Per and Cry mRNA rhythms. However, the 
models predicted that miR-219 functioned to reduce the period of Per mRNA 
oscillations. Supporting this prediction are observations from Cheng et al. (2007), who 
recently demonstrated that knockdown of miR-219 in the SCN resulted in lengthening of 
the free-running period of locomotor activity. Additionally, in vitro assays described in 
the same report had also indicated that both miR-219 and miR-132, independently 
enhanced Per1 transcriptional activation. Thus, these miRNAs positively regulate a 
component of the negative limb of classical feed-back loop. In comparison, our results 
implicating miR-142-3p and miR-494 as repressors of Bmal1 position them as negative 
regulators of the positive limb, in turn slowing down Per1 transcriptional activation. 
Indeed, overexpression of miR-142-3p and miR-494 increases the period of PER2::LUC 
reported bioluminescence rhythms, an effect in opposition to that predicted for 
overexpression of miR-219.  
Much like effects of kinases and phosphatases, or ROR’s and REV-ERB’s, this 
antagonistic relationship between two regulators is not unusual in the circadian system. 
Both miR-142-3p and miR-219 are rhythmically regulated, clock-controlled miRNAs 
and may counter-act each other’s effects on Per1 transcription. It is also noteworthy that 
miR-142-3p directly targets Bmal1 while the effect of miR-219 on Per1 is likely 
indirect, potentially inducing a lag between the two opposing actions. 
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Figure 20: Simplified model of possible mechanisms for miRNA modulation of Per1 
transcription. CLOCK-BMAL1 heterodimers bind to E-box enhancer in miR-142-3p and 
miR-219 promoters and drive their rhythmic transcription. miR-219 inhibits yet 
unknown negative regulator(s), consequently enhancing Per1 transcription and 
‘speeding up’ the oscillatory cycle. In contrast, miR-142-3p feeds back to repress 
BMAL1 protein, consequently attenuating Per1 transcription and ‘slowing down’ the 
oscillatory cycle. Additionally, by repressing BMAL1, miR-142-3p negatively regulates 
of its own transcription and of miR-219 as well. 
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 miRNAs as Signaling Molecules in Local Synchronization of Rhythms 
The studies described in this dissertation also indicate a role for miRNAs in 
temporal synchronization of clocks within local environments in peripheral tissues. 
Primary findings reported in chapters III and IV in support of this are: 1) extracellular 
levels of miR-494 are characterized by rhythmic expression in mouse serum, 2) miR-
494, both independently and in synergy with miR-142-3p, targets the Bmal1 3’ UTR, 3) 
combinatorial overexpression of miR-142-3p and miR-494 represses BMAL1 protein 
levels and disrupts ensemble circadian rhythms of fibroblast cells in vitro, 4) miR-142-
3p and miR-494 are exported out of cells and into the extracellular environment in vitro, 
5) extracellular miR-142-3p is communicated between spatially separated cells in vitro, 
and 6) inhibition of vesicular communication between cells disrupts ensemble circadian 
rhythms in vitro.  
We estimated expression of ~6,500 and ~80,000 molecules of miR-152 and miR-
16 per milliliter of blood respectively. Intracellular expression of miRNAs has been 
estimated to range from a few to multiple thousand molecular per cell depending on cell 
type and the miRNAs under consideration. Thus, given the expression levels in serum, 
the limited set of circulating miRNAs examined during this dissertation are unlikely to 
function as systemic signals synchronizing all peripheral oscillators; their expression 
levels may not be high enough for global function. However, within local environments, 
as demonstrated by the in vitro experiments, communication of extracellular miRNAs 
may be relevant or indeed important for maintenance of temporal synchronization 
between cell-autonomous oscillators.  
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 It is noteworthy that miRNAs, or other small molecule transmitters like ATP or 
cAMP, have certain advantages as signaling molecules because, 1) they may be 
energetically more efficient to produce than proteins, hormones or even small peptides, 
2) they may be easier to transport via vesicles, 3) small regulatory RNAs like miRNAs 
can modulate a large number of genes (up to 200 target genes for individual miRNAs: 
Lewis et al., 2005), 4) miRNA form multi-turnover complexes, thus magnifying the 
effects of even small changes in miRNA levels, and 5) if presence and communication of 
AGO2-complexed miRNAs in serum is verified, extracellular miRNAs could 
conceivably also be transmitted between cells as functional units facilitating rapid 
regulation by the transported miRNA species in recipient cells. Communication of 
extracellular miRNAs has already been documented in important physiological and 
pathological phenomenon including vascular disease, immune function, virus infection 
and hepatocellular carcinoma (Pegtel et al., 2010; Zhang et al., 2010; Kogure et al., 
2011; Mittelbrunn et al., 2011).  
Diurnal oscillations in circulating miR-494 levels in mouse serum and in vitro 
data demonstrating miR-142-3p transfer between cells provide primary insight that 
extracellular miRNAs may also play a role in circadian physiology as well. This system 
could be regulated at multiple levels and data-mining from previous microarray 
experiments provides exciting indications that miRNA synthesis and miRNA packaging 
or secretion may be clock-controlled. Using publically available circadian micro-array 
database (http://bioinf.itmat.upenn.edu/circa), I have examined whether mature miRNA 
production, which is an outcome of Dicer1 activity, may be rhythmic. Interestingly, 
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 Dicer1 mRNA has indications of circadian rhythmicity in skeletal muscle and liver of 
mice. The mRNA peaks around mid-subjective-day in both tissues and reaches a nadir 
around mid-subjective-night. More crucial for rhythmic miRNA secretion is their 
packaging and vesicular release, which was shown by Kosaka et al. (2010) to be under 
control of a ceramide-dependent pathway. Ceramide synthesis itself is thought to be 
regulated by the enzyme acidic spingiomyelinase (aSMase) and/or by the enzyme neutral 
spingiomyelinase (nSMase). Kosaka et al. (2010) demonstrated that both GW4869, an 
nSMase-inhibitor drug and siRNA mediated RNA-interference of nSMase2 effectively 
knocked down secretion of miRNAs in HEK293 cells. Thus data from microarray 
experiments indicating high amplitude rhythms in nSMase transcript abundance in the 
mouse liver, kidney and adrenal glands are exciting and promising. The nSMase 
expression peaks during early- to mid- subjective day and reaches trough values during 
early-subjective night in the liver and during mid- to late- subjective night in kidney and 
adrenal gland. There is also indication of low amplitude rhythms in nSMase in the 
mouse SCN. Thus the circadian clock may impinge on miRNA secretion pathway(s) to 
rhythmically regulate extracellular miRNA-mediated communication and this regulation 
may be critical for physiology and pathologies, including circadian rhythms disorders, 
metabolic disorders and even certain cancers.  
 
Remaining Questions and Concluding Remarks 
The studies presented in this dissertation are a step towards exploring the 
contribution of miRNAs to post-transcriptional regulation of the circadian clock. I have 
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 reported some mechanistic details underlying regulation of the miRNA, miR-142-3p, 
and described how it feeds back to target its activator, Bmal1. I have focused on an 
additional miRNA, miR-494 that also targets Bmal1, to study extracellular expression 
and function of miRNAs. Given that miRNAs are estimated to regulate 30-50% of the 
transcriptome and between 10-30% of the transcriptome is also under circadian 
regulation, significant insights into the contribution of miRNAs to rhythmic physiology 
and behaviors have yet to be determined.  
The groundwork laid during this dissertation has however generated some 
interesting questions. What other miRNAs are rhythmically transcribed in the SCN? 
How is their expression regulated? What are their targets? How do non-cyclic miRNAs 
affect the rhythmic transcriptome? Important tools for initial forays into answering some 
of these questions are already available. BMAL1 ChIP-sequencing experiments have 
been carried out to identify targets of the CLOCK-BMAL1 heterodimer complex 
(Hatanaka et al., 2010, Rey et al., 2011). With non-coding genomic regions better 
annotated than ever, those ChIP-Seq data could be revisited to potentially detect 
miRNAs or other regulatory RNAs that had previously been missed. Over the past few 
years, databases of validated miRNA targets have also become available, which are a 
useful tool for verifying if miRNA regulators of a potential mRNA of interest have 
already been identified. Concurrently, a method for identification of miRNA targets has 
also been described in Drosophila (Kadener et al., 2009). At various timepoints in a 
circadian cycle, AGO1 was immunoprecipitated and bound mRNAs were identified by 
microarray analysis. Because the AGO family of proteins (4 members in mammals) are 
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 primarily responsible for miRISC-mediated transcriptional silencing, this procedure can 
potentially identify all mRNAs actively associated with repression complexes. This 
method could perhaps also be coupled to sequencing of the immunoprecipitated 
complexes to identify both, miRNAs and their corresponding mRNA targets.  
Research into the regulatory functions of extracellular miRNAs is rapidly 
advancing and the studies described in this dissertation provide a glimpse into the role of 
extracellular miRNAs in communication of temporal information. However, many 
questions yet remain unanswered. For example, how are miRNAs packaged? Does the 
circadian machinery contribute to sorting of miRNAs for extracellular release? What 
organs contribute miRNAs to the circulating miRNA pool? What are the identities of 
circulating miRNA species, and how many of them are rhythmic? Is miRNA secretion or 
miRNA uptake rhythmically regulated? Is there targeted communication of miRNA 
signals between cells? Given how little we know about extracellular miRNAs, these 
questions are arguably much harder to address. So how and where do we begin? An 
ideal system for such analyses would allow one to disassociate peripheral rhythms from 
SCN influence, and then determine the potential contributions of circulating miRNAs to 
synchronization of peripheral clocks. In this regard, one of the best characterized 
paradigms for studying peripheral rhythms independent of SCN influence, is that of 
restricted feeding. Rhythms in peripheral tissues in SCN lesioned animals under 
restricted feeding conditions have already been well documented (Honma et al., 1988). 
Using SCN-lesioned, wild-type and tissue-specific conditional Dicer knockout mice, it 
could be possible to compare the rhythmic mRNA transcriptome of various peripheral 
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 tissues as well the rhythmic circulating miRNA’ome under ad-lib or restricted feeding 
paradigms. This could help answer some potential questions including, 1) what is the 
relative contribution of individual organs (e.g. the liver) to the circulating miRNA’ome, 
2) how does the circulating miRNA’ome vary between ad-lib fed, and restricted feeding 
conditions, and 3) is there an effect of miRNA knockdown in one tissue on identities 
and/or phases of cycling genes in other peripheral tissues. With regard to the potential 
influence of the circadian clock on rhythmic packaging and secretion of miRNAs, the 
extracellular miRNA’ome of wild-type and arrhythmic clock mutant mice could be 
profiled to identify candidate circulating miRNAs that are rhythmically regulated. 
Additionally, an interesting question that remains to be addressed in vivo is whether 
miRNAs are communicated between spatially separated cells. This could possibly be 
investigated using tissue specific expression of ‘foreign’ miRNAs (i.e., miRNAs lacking 
any sequence homology with endogenous generated miRNAs.) Analysis of other closely 
associated tissues for presence of this foreign miRNA may shed light on whether 
miRNAs are exchanged between cell-types in vivo.  
In summary, the research described here represents initial advances and exciting 
possibilities regarding the role miRNAs could play in regulation of circadian physiology 
and pathologies by targeting clock genes in SCN pacemaker and peripheral oscillators. 
Molecular, genetic and cell culture tools available for murine models provide strong 
foundations and excellent resources for further illuminating the circadian regulatory 
functions of miRNAs. 
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